1
|
Gonçalves JPL, Bollwein C, Noske A, Jacob A, Jank P, Loibl S, Nekljudova V, Fasching PA, Karn T, Marmé F, Müller V, Schem C, Sinn BV, Stickeler E, van Mackelenbergh M, Schmitt WD, Denkert C, Weichert W, Schwamborn K. Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging. Int J Mol Sci 2023; 24:ijms24032860. [PMID: 36769215 PMCID: PMC9918176 DOI: 10.3390/ijms24032860] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2022] [Revised: 01/27/2023] [Accepted: 01/31/2023] [Indexed: 02/05/2023] Open
Abstract
Immunohistochemical evaluation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 status stratify the different subtypes of breast cancer and define the treatment course. Triple-negative breast cancer (TNBC), which does not register receptor overexpression, is often associated with worse patient prognosis. Mass spectrometry imaging transcribes the molecular content of tissue specimens without requiring additional tags or preliminary analysis of the samples, being therefore an excellent methodology for an unbiased determination of tissue constituents, in particular tumor markers. In this study, the proteomic content of 1191 human breast cancer samples was characterized by mass spectrometry imaging and the epithelial regions were employed to train and test machine-learning models to characterize the individual receptor status and to classify TNBC. The classification models presented yielded high accuracies for estrogen and progesterone receptors and over 95% accuracy for classification of TNBC. Analysis of the molecular features revealed that vimentin overexpression is associated with TNBC, supported by immunohistochemistry validation, revealing a new potential target for diagnosis and treatment.
Collapse
Affiliation(s)
- Juliana Pereira Lopes Gonçalves
- Institute of Pathology, School of Medicine, Technical University of Munich, Trogerstraße 18, 81675 Munich, Germany
- German Cancer Consortium (DKTK), Partner Site Munich, 80336 Munich, Germany
| | - Christine Bollwein
- Institute of Pathology, School of Medicine, Technical University of Munich, Trogerstraße 18, 81675 Munich, Germany
| | - Aurelia Noske
- Institute of Pathology, School of Medicine, Technical University of Munich, Trogerstraße 18, 81675 Munich, Germany
| | - Anne Jacob
- Institute of Pathology, School of Medicine, Technical University of Munich, Trogerstraße 18, 81675 Munich, Germany
| | - Paul Jank
- Institute of Pathology, Philipps-University Marburg and University Hospital Marburg (UKGM), 35043 Marburg, Germany
| | - Sibylle Loibl
- German Breast Group (GBG), 63263 Neu-Isenburg, Germany
| | | | - Peter A. Fasching
- Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), 91054 Erlangen, Germany
| | - Thomas Karn
- Department of Gynecology and Obstetrics, Goethe-University Frankfurt, 60590 Frankfurt, Germany
| | - Frederik Marmé
- Department of Obstetrics and Gynecology, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany
| | - Volkmar Müller
- Department of Gynecology, Universitätsklinikum Hamburg-Eppendorf, 20251 Hamburg, Germany
| | | | | | - Elmar Stickeler
- Department of Obstetrics and Gynecology, University Hospital Aachen, 52074 Aachen, Germany
| | - Marion van Mackelenbergh
- Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, 24105 Kiel, Germany
| | | | - Carsten Denkert
- Institute of Pathology, Philipps-University Marburg and University Hospital Marburg (UKGM), 35043 Marburg, Germany
| | - Wilko Weichert
- Institute of Pathology, School of Medicine, Technical University of Munich, Trogerstraße 18, 81675 Munich, Germany
- German Cancer Consortium (DKTK), Partner Site Munich, 80336 Munich, Germany
| | - Kristina Schwamborn
- Institute of Pathology, School of Medicine, Technical University of Munich, Trogerstraße 18, 81675 Munich, Germany
- Correspondence:
| |
Collapse
|
2
|
Toupin S, Pezel T, Hovasse T, Sanguineti F, Champagne S, Unterseeh T, Chitiboi T, Jacob A, Borgohain I, Sharma P, Garot P, Garot J. Incremental prognostic value of fully-automatic LVEF by stress CMR using machine learning. Archives of Cardiovascular Diseases Supplements 2023. [DOI: 10.1016/j.acvdsp.2022.10.117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
3
|
Pezel T, Hovasse T, Toupin S, Sanguineti F, Garot P, Champagne S, Chitiboi T, Jacob A, Borgohain I, Sharma P, Unterseeh T, Garot J. Additional prognostic value of fully automatic global longitudinal strain using machine learning. Archives of Cardiovascular Diseases Supplements 2023. [DOI: 10.1016/j.acvdsp.2022.10.113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
4
|
Kaliamurthi P, Karunya J, Sathyamurthy A, John NO, Ram T, Babu A, Jacob A, Megalai M. Prehabilitation in Locally Advanced Cervical Cancer Patients Receiving Radiotherapy. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.1246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
5
|
Nesbitt K, Beleigoli A, Champion S, Gebremichael L, Jacob A, Du H, Hendriks J, Tirimacco R, Clark RA. Evaluating the usability of a co-designed interactive web application for cardiac rehabilitation. Eur J Cardiovasc Nurs 2022. [DOI: 10.1093/eurjcn/zvac060.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Novartis
Background/significance
The rapid development of information technology is driving the evolution of choices of modes of delivery of healthcare services. The internet is an extremely powerful tool for accessing information, and communication. However, involvement of patients in the assessment of such an intervention is crucial, and can be achieved through a person-centred approach, utilising a co-design process with the aim to increase intervention usability.
Purpose
To assess the usability of the Country Access to Cardiac Health (CATCH) Web, an interactive web application for cardiac rehabilitation (CR), co-designed with rural and remote Australians, following the co-design development phase.
Methods
The User Experience (UX) Design framework was used to co-design the web portal with CR patients through two rounds of six co-design workshops pre (n=39), and post (n=35). Participants and family members living in rural and remote areas of Australia were invited to participate based on their eligibility for CR as outlined by the National Heart Foundation of Australia. As part of the UX Design Framework the System Usability Scale (SUS) was used to measure objective feedback from participants on the website design. The SUS assesses the three core components of a products usability: effectiveness, efficiency and satisfaction using a 10 question Likert scale. Mean scores were compared between the two rounds of workshops using an independent T-Test. The mean SUS score is categorised into poor to moderate (<68), good (68-80.3) and excellent (>=80.3) and categories were compared between the two rounds of workshops through Chi-Square tests.
Results
The 35 participants in the usability workshops had a mean age of 68.6 (SD 11.2) years and 16 (47%) were female (Table 1). The majority had experienced a myocardial infarction (15, 42.8%) and had hyperlipidemia (17, 50%), heart failure (15, 44%), hypertension (14, 41%), and Type II diabetes (7, 21%). Of these participants 20 (59%) used a smart phone, 18 (58%) had access to the National Broadband Network and 20 (59%) engaged with Facebook. From the first to the second round of workshops, there was an improvement in the mean SUS scores from 66.7 (SD16.8) to 73.6 (SD 21.0); p=0.26. The proportion of participants rating it as good or excellent increased from 48.7 to 65.8%; p=0.11 (Figure1).
Conclusion
The usability testing of the interactive CATCH web application showed an improvement in the SUS rating from poor to moderate in the co-design development phase to good or excellent by most of the participants in the usability testing phase. Usability is closely related to engagement with a digital health intervention. Upcoming evaluation of this intervention will report on clinical outcomes.
Collapse
Affiliation(s)
- K Nesbitt
- Flinders University , Adelaide , Australia
| | | | - S Champion
- Flinders University , Adelaide , Australia
| | | | - A Jacob
- Flinders University , Adelaide , Australia
| | - H Du
- Flinders University , Adelaide , Australia
| | - J Hendriks
- Flinders University , Adelaide , Australia
| | - R Tirimacco
- Integrated Cardiovascular Clinical Network , Adelaide , Australia
| | - R A Clark
- Flinders University , Adelaide , Australia
| |
Collapse
|
6
|
KEEPPALLIL K, Jacob A, Abraham G. POS-334 Urinary Tract Infections in immunocompromised patients with diabetes and correlation with renal dysfunction - a single centre experience. Kidney Int Rep 2022. [DOI: 10.1016/j.ekir.2022.01.355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
7
|
Perrin C, Jacob A, Lucas A, Myhill R, Hauber E, Batov A, Gudkova T, Rodriguez S, Lognonné P, Stevanović J, Drilleau M, Fuji N. Geometry and Segmentation of Cerberus Fossae, Mars: Implications for Marsquake Properties. J Geophys Res Planets 2022; 127:e2021JE007118. [PMID: 35847353 PMCID: PMC9285074 DOI: 10.1029/2021je007118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/01/2021] [Revised: 12/20/2021] [Accepted: 01/10/2022] [Indexed: 06/15/2023]
Abstract
The NASA InSight mission to Mars successfully landed on 26 November 2018 in Elysium Planitia. It aims to characterize the seismic activity and aid in the understanding of the internal structure of Mars. We focus on the Cerberus Fossae region, a giant fracture network ∼1,200 km long situated east of the InSight landing site where M ∼3 marsquakes were detected during the past 2 years. It is formed of five main fossae located on the southeast of the Elysium Mons volcanic rise. We perform a detailed mapping of the entire system based on high-resolution satellite images and Digital Elevation Models. The refined cartography reveals a range of morphologies associated with dike activity at depth. Width and throw measurements of the fossae are linearly correlated, suggesting a possible tectonic control on the shapes of the fossae. Widths and throws decrease toward the east, indicating the long-term direction of propagation of the dike-induced graben system. They also give insights into the geometry at depth and how the possible faults and fractures are rooted in the crust. The exceptional preservation of the fossae allows us to detect up to four scales of segmentation, each formed by a similar number of 3-4 segments/subsegments. This generic distribution is comparable to continental faults and fractures on Earth. We anticipate higher stress and potential marsquakes within intersegment zones and at graben tips.
Collapse
Affiliation(s)
- C. Perrin
- Université de ParisInstitut de physique du globe de ParisCNRSParisFrance
- Now at Nantes UniversitéUniversité d’AngersLe Mans UniversitéCNRS, UMR 6112, Laboratoire de Planétologie et GéosciencesUAR 3281, Observatoire des Sciences de l’Univers de Nantes AtlantiqueNantesFrance
| | - A. Jacob
- Université de ParisInstitut de physique du globe de ParisCNRSParisFrance
| | - A. Lucas
- Université de ParisInstitut de physique du globe de ParisCNRSParisFrance
| | - R. Myhill
- School of Earth SciencesUniversity of BristolBristolUK
| | - E. Hauber
- DLR Institute of Planetary ResearchBerlinGermany
| | - A. Batov
- Schmidt Institute of Physics of the EarthRussian Academy of SciencesMoscowRussia
- V.A. Trapeznikov Institute of Control SciencesRussian Academy of SciencesMoscowRussia
| | - T. Gudkova
- Schmidt Institute of Physics of the EarthRussian Academy of SciencesMoscowRussia
| | - S. Rodriguez
- Université de ParisInstitut de physique du globe de ParisCNRSParisFrance
| | - P. Lognonné
- Université de ParisInstitut de physique du globe de ParisCNRSParisFrance
| | | | - M. Drilleau
- Institut Supérieur de l’Aéronautique et de l’Espace ISAE‐SUPAEROToulouseFrance
| | - N. Fuji
- Université de ParisInstitut de physique du globe de ParisCNRSParisFrance
| |
Collapse
|
8
|
Dileepkumar R, Anaswara K, Navya V, Beena S, Jacob A, Divya L, Vijayasree AS, Deepthi V, Renganayaki G, Shidhi PR, Akbarsha MA, Laladhas KP, Nair AS, Sudhakaran PR, Oommen OV. Black Palm Squirrel (<i>Funambulus palmarum</i> Linn.) from India: Association with a Frame Shift Mutation in the MC1R Gene. CURR SCI INDIA 2021. [DOI: 10.18520/cs/v121/i2/306-312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
9
|
Jacob A, Hubert D, Grenet D, Brain C, Flahault C. P255 Parenthood experience of cystic fibrosis patients and their spouses. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)01280-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
10
|
Veyrier M, Ariouat I, Jacob A, Trout H, Bloch V, Delavest M, Bellivier F, Geoffroy PA. Use of immediate release melatonin in psychiatry: BMI impacts the daily-dose. Encephale 2020; 47:96-101. [PMID: 33349460 DOI: 10.1016/j.encep.2020.08.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2020] [Revised: 07/28/2020] [Accepted: 08/08/2020] [Indexed: 12/31/2022]
Abstract
OBJECTIVE There is a growing interest in psychiatry regarding melatonin use both for its soporific and chronobiotic effects. This study aimed to evaluate factors impacting the daily-dose. METHODS In a university department of psychiatry in Paris (France), we conducted a posteriori naturalistic observational study from April 03, 2017 to January 31, 2018. We assessed links between sociodemographic and clinical characteristics and daily dose of melatonin (the daily-dose of melatonin initiation and the daily-dose at Hospital discharge). A survey of drug interactions was performed regarding metabolic inducers and inhibitors of the cytochrome P450 1A2. RESULTS Forty patients were included and treated with immediate-release melatonin. For patients with no history of melatonin use, the initiation dose of was 2 or 4mg, with no effects of age, weight, BMI, melatonin indication, cause of hospitalization. We found that higher discharge dose was associated with higher BMI (P=0.036) and more reevaluations of melatonin dose (P=0.00019). All patients with a moderate inducer (n=3, here lansoprazole) were significantly more associated with the discontinuation melatonin group (P=0.002). CONCLUSION The BMI and the number of reevaluations impact the daily dose of melatonin. Two mechanisms may explain that BMI may need higher doses: (i) melatonin diffuses into the fat mass, (ii) the variant 24E on melatonin receptor MT2, more frequent in obese patients, leads to a decrease of the receptor signal.
Collapse
Affiliation(s)
- M Veyrier
- Service Pharmacie, AP-HP, GH Saint-Louis-Lariboisière-F. Widal, 75475 Paris cedex 10, France.
| | - I Ariouat
- Service Pharmacie, AP-HP, GH Saint-Louis-Lariboisière-F. Widal, 75475 Paris cedex 10, France
| | - A Jacob
- Service Pharmacie, AP-HP, GH Saint-Louis-Lariboisière-F. Widal, 75475 Paris cedex 10, France; Iserm U1144 optimisation thérapeutique en neuropsychopharmacologie, université Paris Descartes, université Paris Diderot, université Sorbonne Paris Cité, Paris, France
| | - H Trout
- Service Pharmacie, AP-HP, GH Saint-Louis-Lariboisière-F. Widal, 75475 Paris cedex 10, France
| | - V Bloch
- Service Pharmacie, AP-HP, GH Saint-Louis-Lariboisière-F. Widal, 75475 Paris cedex 10, France; Iserm U1144 optimisation thérapeutique en neuropsychopharmacologie, université Paris Descartes, université Paris Diderot, université Sorbonne Paris Cité, Paris, France
| | - M Delavest
- Département de Psychiatrie et de Médecine Addictologique, AP-HP, GH Saint-Louis-Lariboisière-F. Widal, 75475 Paris cedex 10, France
| | - F Bellivier
- Iserm U1144 optimisation thérapeutique en neuropsychopharmacologie, université Paris Descartes, université Paris Diderot, université Sorbonne Paris Cité, Paris, France; Département de Psychiatrie et de Médecine Addictologique, AP-HP, GH Saint-Louis-Lariboisière-F. Widal, 75475 Paris cedex 10, France
| | - P A Geoffroy
- Iserm U1144 optimisation thérapeutique en neuropsychopharmacologie, université Paris Descartes, université Paris Diderot, université Sorbonne Paris Cité, Paris, France; Département de Psychiatrie et de Médecine Addictologique, AP-HP, GH Saint-Louis-Lariboisière-F. Widal, 75475 Paris cedex 10, France.
| |
Collapse
|
11
|
Jacob A, Swamy K, Maiya VM, R P, Kallur K, Pichandi A, Kumar BA. Preoperative Chemoradiation In Rectal Cancer: Predicting Complete Pathological Responders Through Metabolic Imaging. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.1940] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
12
|
Journiac J, Vioulac C, Jacob A, Escarnot C, Untas A. What Do We Know About Young Adult Cardiac Patients' Experience? A Systematic Review. Front Psychol 2020; 11:1119. [PMID: 32733301 PMCID: PMC7358619 DOI: 10.3389/fpsyg.2020.01119] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2019] [Accepted: 04/30/2020] [Indexed: 12/23/2022] Open
Abstract
Background: Studies interested in patients coping with a cardiac illness usually focus on children, teenagers, and adults above the age of 55. Apart from the field of congenital heart diseases, there is a general lack of literature regarding young adult cardiac patients (18-55 years old) who seem to cope with psychosocial issues. Therefore, the objective of this paper was to gather all the research carried out concerning the psychological experiences of young adult cardiac patients. Methods and Results: A comprehensive, systematic review was conducted on quantitative, qualitative, and mixed-method studies in PsycINFO, PubMed, ScienceDirect, and Cochrane Library databases. Out of the 10,747 articles found, 32 were included. While we aimed to include many cardiac diseases, coronary patients dominated the data. Five main themes emerged: emotional states (depression, anxiety, emotional distress, and stress), quality of life (health-related quality of life, physical functioning, and sexuality), adjusting to the medical environment (coping with the disease, health behavior change, financial barriers, and interactions with medical professionals), social life (social support and work), and identity (parenthood, new challenges, and new meanings). The results highlighted that their levels of depression, anxiety, stress, and quality of life were sometimes worse than in the general population and than in older and younger patients coping with a cardiac illness. Social isolation, identity changes, work, and parenthood were the specific challenges that this population had to face. Furthermore, young adult cardiac patients showed worse health behavior profiles than the general population and felt that they lacked information from professionals, especially regarding sexuality. Compared to men, women had worse psychosocial outcomes, especially regarding depression, stress, emotional distress, and quality of life. Conclusions: Young adult cardiac patients are to be considered with their own identity and challenges. They may be in need of specific interventions, some dedicated to women, and better communication is necessary with their families and professional caregivers so as to improve the patient's mental health, quality of life, coping skills, and adherence.
Collapse
Affiliation(s)
| | | | - Anne Jacob
- Université de Paris, LPPS, Boulogne-Billancourt, France
| | | | - Aurélie Untas
- Université de Paris, LPPS, Boulogne-Billancourt, France
| |
Collapse
|
13
|
Jacob A, Hubert D, Grenet D, Abdoul H, Flahault C. P358 How do cystic fibrosis patients experience parenthood? An explorative study. J Cyst Fibros 2020. [DOI: 10.1016/s1569-1993(20)30686-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
14
|
Jacob A, Journiac J, Fischer L, Astrologo L, Flahault C. How do cystic fibrosis patients experience parenthood? A systematic review. J Health Psychol 2020; 26:60-81. [DOI: 10.1177/1359105320916539] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Improved treatments for cystic fibrosis allow more patients to become parents. This article presents a systematic review of literature on cystic fibrosis patients’ experience of parenthood. Five databases (Cairn, Cochrane Library, PsycINFO, PubMed and ScienceDirect) produced 2335 documents that were screened. In total, 13 documents were retained and assessed with validated criteria. Five themes related to cystic fibrosis parenthood were discovered: population presentation, health and treatment adherence, adjustments, role of professionals and pressured temporality. Parenthood requires an important reorganisation of daily life in order to remain capable of childcare. Regardless of negative health impacts, cystic fibrosis parents have a positive outlook on parenthood.
Collapse
Affiliation(s)
- Anne Jacob
- Laboratoire de Psychopathologie et Processus de Santé (LPPS), Université de Paris, Institut de Psychologie, Boulogne-Billancourt, France
| | - Jonathan Journiac
- Laboratoire de Psychopathologie et Processus de Santé (LPPS), Université de Paris, Institut de Psychologie, Boulogne-Billancourt, France
| | - Lotte Fischer
- Laboratoire de Psychopathologie et Processus de Santé (LPPS), Université de Paris, Institut de Psychologie, Boulogne-Billancourt, France
- Service d’Addictologie, Hôpital René-Muret (AP-HP), Hôpitaux Universitaires Paris Seine-Saint-Denis (HUPSSD), Sevran, France
| | - Lisa Astrologo
- Interpersonal Relationships and Development Laboratory, Centre for Research in Human Development, Department of Psychology, Concordia University, Montreal, QC, Canada
| | - Cécile Flahault
- Laboratoire de Psychopathologie et Processus de Santé (LPPS), Université de Paris, Institut de Psychologie, Boulogne-Billancourt, France
- Psychiatrie de l’Adulte et du Sujet Âgé, Hôpital Européen Georges-Pompidou, Paris, France
- Unité de Psycho-Oncologie, Institut Gustave Roussy, Villejuif, France
| |
Collapse
|
15
|
Mueller SM, Gantenbein L, Navarini A, Ständer S, Jacob A, Popko L. The first mention of itch in history? When Egyptologists scratch their heads. J Eur Acad Dermatol Venereol 2020; 34:1642-1643. [PMID: 32143240 DOI: 10.1111/jdv.16133] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- S M Mueller
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - L Gantenbein
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - A Navarini
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - S Ständer
- Department of Dermatology and Center for Chronic Pruritus, University Hospital Münster, Münster, Germany
| | - A Jacob
- Institute for the Study of the Ancient World, New York University, New York, USA
| | - L Popko
- Sächsische Akademie der Wissenschaften, Projekt "Strukturen und Transformationen des Wortschatzes der Ägyptischen Sprache", c/o Ägyptologisches Institut der Universität Leipzig, Leipzig, Germany
| |
Collapse
|
16
|
Gal A, Burton SE, Weidgraaf K, Singh P, Lopez-Villalobos N, Jacob A, Malabu U, Burchell R. The effect of the sodium-glucose cotransporter type-2 inhibitor dapagliflozin on glomerular filtration rate in healthy cats. Domest Anim Endocrinol 2020; 70:106376. [PMID: 31585313 DOI: 10.1016/j.domaniend.2019.07.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/06/2019] [Revised: 06/17/2019] [Accepted: 07/10/2019] [Indexed: 11/29/2022]
Abstract
Sodium-glucose cotransporter type-2 inhibitors (SGLT2is) reduce glomerular hyperfiltration in diabetic people with early diabetic nephropathy. The objective of this report was to assess changes in glomerular filtration rate in healthy cats after treatment with a SGLT2i. Eight healthy research adult castrated male cats were used in a randomized, controlled, cross-over study design. We induced isolated renal tubular glucosuria by dosing cats with the SGLT2i dapagliflozin. The cats received by mouth 10 mg dapagliflozin or control every 24 h in each of the 4, 5-d trial periods that were separated by a 7-d washout period. We assessed glomerular filtration rate (iohexol clearance method), serum urea, creatinine, symmetric dimethylarginine, and 24-h sodium and chloride urinary excretion on the fifth day of each trial period. We analyzed the data with a mixed linear model that included the fixed effects of treatment (treated and control) and trial period, and the random effect of the cat. Compared with controls, cats treated with dapagliflozin had a significant increase in mean (±SE) glomerular filtration rate (3.1 ± 0.2 vs 2.5 ± 0.2 mL/kg/min; P = 0.01), whereas there were no significant differences in serum urea, creatinine and symmetric dimethylarginine, and 24-h urine sodium and chloride excretion. We propose that dapagliflozin-mediated delivery of sodium and glucose distal from the proximal convoluted tubule induced compensatory increased sodium absorption at the thick ascending loop of Henle that resulted in decreased sodium delivery to the distal tubule leading to tubuloglomerular feedback-mediated glomerular hyperfiltration. Future studies should determine if SGLT2is' renoprotective effect in people can be enhanced with the addition of a Na+-K+-Cl- diuretic and whether dapagliflozin will be useful in mitigating proteinuria and hypertension that follow glomerular hyperfiltration in diabetic companion animals in a similar mechanism as in people.
Collapse
Affiliation(s)
- A Gal
- Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
| | - S E Burton
- School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand
| | - K Weidgraaf
- School of Agriculture and Environment, Massey University, Palmerston North, New Zealand
| | - P Singh
- School of Veterinary Science, Massey University, Palmerston North, New Zealand
| | - N Lopez-Villalobos
- School of Agriculture and Environment, Massey University, Palmerston North, New Zealand
| | - A Jacob
- School of Veterinary Science, Massey University, Palmerston North, New Zealand
| | - U Malabu
- School of Medicine, James Cook University, Townsville, Queensland, Australia
| | - R Burchell
- School of Veterinary Science, James Cook University, Townsville, Queensland, Australia
| |
Collapse
|
17
|
Jacob A, Wüst HM, Thalhammer JM, Fröb F, Küspert M, Reiprich S, Balta EA, Lie DC, Wegner M, Sock E. The transcription factor prospero homeobox protein 1 is a direct target of SoxC proteins during developmental vertebrate neurogenesis. J Neurochem 2019; 146:251-268. [PMID: 29749639 DOI: 10.1111/jnc.14456] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2017] [Revised: 03/20/2018] [Accepted: 04/16/2018] [Indexed: 11/29/2022]
Abstract
The high-mobility-group domain containing SoxC transcription factors Sox4 and Sox11 are expressed and required in the vertebrate central nervous system in neuronal precursors and neuroblasts. To identify genes that are widely regulated by SoxC proteins during vertebrate neurogenesis we generated expression profiles from developing mouse brain and chicken neural tube with reduced SoxC expression and found the transcription factor prospero homeobox protein 1 (Prox1) strongly down-regulated under both conditions. This led us to hypothesize that Prox1 expression depends on SoxC proteins in the developing central nervous system of mouse and chicken. By combining luciferase reporter assays and over-expression in the chicken neural tube with in vivo and in vitro binding studies, we identify the Prox1 gene promoter and two upstream enhancers at -44 kb and -40 kb relative to the transcription start as regulatory regions that are bound and activated by SoxC proteins. This argues that Prox1 is a direct target gene of SoxC proteins during neurogenesis. Electroporations in the chicken neural tube furthermore show that Prox1 activates a subset of SoxC target genes, whereas it has no effects on others. We propose that the transcriptional control of Prox1 by SoxC proteins may ensure coupling of two types of transcription factors that are both required during early neurogenesis, but have at least in part distinct functions. Open Data: Materials are available on https://cos.io/our-services/open-science-badges/ https://osf.io/93n6m/.
Collapse
Affiliation(s)
- Anne Jacob
- Institut für Biochemie, Emil-Fischer-Zentrum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Hannah M Wüst
- Institut für Biochemie, Emil-Fischer-Zentrum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Johannes M Thalhammer
- Institut für Biochemie, Emil-Fischer-Zentrum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Franziska Fröb
- Institut für Biochemie, Emil-Fischer-Zentrum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Melanie Küspert
- Institut für Biochemie, Emil-Fischer-Zentrum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Simone Reiprich
- Institut für Biochemie, Emil-Fischer-Zentrum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Elli-Anna Balta
- Institut für Biochemie, Emil-Fischer-Zentrum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - D Chichung Lie
- Institut für Biochemie, Emil-Fischer-Zentrum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Michael Wegner
- Institut für Biochemie, Emil-Fischer-Zentrum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Elisabeth Sock
- Institut für Biochemie, Emil-Fischer-Zentrum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| |
Collapse
|
18
|
Ghia P, Pluta A, Wach M, Lysak D, Kozak T, Simkovic M, Kaplan P, Kraychok I, Illes A, De La Serna J, Dolan S, Campbell P, Musuraca G, Jacob A, Avery E, Lee J, Chen T, Liang W, Patel P, Jurczak W. Acalabrutinib vs Rituximab Plus Idelalisib (IdR) or Bendamustine (BR) by Investigator Choice in Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia: Phase 3 ASCEND Study. Hematol Oncol 2019. [DOI: 10.1002/hon.54_2629] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- P. Ghia
- Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele; Milano Italy
| | - A. Pluta
- Department of Hematological Oncology; Oncology Specialist Hospital; Brzozow Poland
| | - M. Wach
- Department of Hemato-Oncology and Bone Marrow Transplantation; Medical University of Lublin; Lublin Poland
| | - D. Lysak
- Fakultní Nemocnice Plzeň; Pilsen Czech Republic
| | - T. Kozak
- Fakultní Nemocnice Královske Vinohrady; Prague Czech Republic
| | - M. Simkovic
- University Hospital Hradec Kralove; Charles University; Hradec Kralove Czech Republic
| | - P. Kaplan
- Dnipropetrovsk City Clinical Hospital No. 4; Dnipropetrovsk Ukraine
| | | | - A. Illes
- University of Debrecen, Faculty of Medicine; Department of Hematology; Hungary
| | | | - S. Dolan
- Saint John Regional Hospital; University of New Brunswick; New Brunswick Canada
| | - P. Campbell
- Barwon Health; University Hospital Geelong; Geelong Victoria Australia
| | - G. Musuraca
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori; Meldola Italy
| | - A. Jacob
- The Royal Wolverhampton NHS Trust; Wolverhampton United Kingdom
| | - E.J. Avery
- Nebraska Hematology Oncology; Lincoln NE
| | - J.H. Lee
- Gachon University Gil Medical Center; Incheon South Korea
| | - T. Chen
- Acerta Pharma; South San Francisco CA USA
| | - W. Liang
- Acerta Pharma; South San Francisco CA USA
| | - P. Patel
- Acerta Pharma; South San Francisco CA USA
| | - W. Jurczak
- Department of Hematology; Jagiellonian University Medical College; Krakow Poland
| |
Collapse
|
19
|
Nabieva N, Kellner S, Fehm T, Häberle L, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Wuerstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Fersis N, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesselt T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauss T, Thomssen C, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Jacob A, Schmidt K, Belleville E, Brucker SY, Kümmel S, Beckmann MW, Wallwiener D, Hadji P, Fasching PA. Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients. Ann Oncol 2019; 29:186-192. [PMID: 29045642 DOI: 10.1093/annonc/mdx630] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Background Patients' compliance and persistence with endocrine treatment has a significant effect on the prognosis in early breast cancer (EBC). The purpose of this analysis was to identify possible reasons for non-persistence, defined as premature cessation of therapy, on the basis of patient and tumor characteristics in individuals receiving adjuvant treatment with letrozole. Patients and methods The EvAluate-TM study is a prospective, multicenter, noninterventional study in which treatment with the aromatase inhibitor letrozole was evaluated in postmenopausal women with hormone receptor-positive EBC in the early therapy phase. Treatment persistence was evaluated at two pre-specified study visits after 6 and 12 months. As a measure of early therapy persistence the time from the start to the end of treatment (TTEOT) was analyzed. Cox regression analyses were carried out to identify patient characteristics and tumor characteristics predicting TTEOT. Results Out of the total population of 3941 patients with EBC, 540 (13.7%) events involving treatment cessation unrelated to disease progression were observed. This was due to drug-related toxicity in the majority of cases (73.5%). Persistence rates were 92.2%, 86.9%, and 86.3% after 6, 12, and 15 months, respectively. The main factors influencing premature treatment discontinuation were older age [hazard ratio (HR) 1.02/year], comorbidities (HR 1.06 per comorbidity), low body mass index, and lower tumor grade (HR 0.85 per grade unit). Conclusion These results support the view that older, multimorbid patients with low tumor grade and low body mass index are at the greatest risk for treatment discontinuation and might benefit from compliance and support programs.
Collapse
Affiliation(s)
- N Nabieva
- Department of Gynecology, Erlangen University Hospital, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany
| | - S Kellner
- Department of Gynecology, Erlangen University Hospital, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany
| | - T Fehm
- Department of Gynecology, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany.,Department of Gynecology, University of Tübingen, Tübingen, Germany
| | - L Häberle
- Department of Gynecology, Erlangen University Hospital, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.,Biostatistics Unit, Department of Gynecology, Erlangen University Hospital, Erlangen, Germany
| | - J de Waal
- Department of Gynecology, Dachau Clinic, Dachau, Germany
| | - M Rezai
- Luisen-Hospital Düsseldorf, Düsseldorf, Germany
| | - B Baier
- Department of Gynecology, Dachau Clinic, Dachau, Germany
| | - G Baake
- Oncological Medical Practice Pinneberg, Pinneberg, Germany
| | | | | | - M Warm
- Breast Center, Department of Gynecology, Cologne University Hospital, Cologne, Germany.,Breast Center, Clinics of Cologne gGmbH, Holweide, Cologne, Germany
| | - N Harbeck
- Breast Center, Department of Gynecology, Cologne University Hospital, Cologne, Germany.,Breast Center, Department of Gynecology, University of Munich (LMU), Munich, Germany
| | - R Wuerstlein
- Breast Center, Department of Gynecology, Cologne University Hospital, Cologne, Germany.,Breast Center, Department of Gynecology, University of Munich (LMU), Munich, Germany
| | - J-U Deuker
- Vinzenz-Hospital Hannover GmbH, Hannover, Germany
| | - P Dall
- Department of Gynecology, Lüneburg Clinic, Lüneburg, Germany
| | - B Richter
- Elbland Clinics, Meissen-Radebeul, Germany
| | - G Wachsmann
- County Hospital of Böblingen, Böblingen, Germany
| | - C Brucker
- Department of Gynecology, University Hospital, Paracelsus Private Medical University of Nuremberg, Nuremberg, Germany
| | - J W Siebers
- Department of Gynecology, St. Josef's Hospital, Offenburg, Germany
| | - N Fersis
- Department of Gynecology, Bayreuth Clinic GmbH, CCC ER-EMN, Bayreuth, Germany
| | - T Kuhn
- Karl-Olga-Hospital Stuttgart, Diakonie Klinikum Stuttgart, Stuttgart, Germany
| | - C Wolf
- Medical Center Ulm, Ulm, Germany
| | - H-W Vollert
- Friedrichshafen Clinic, Friedrichshafen, Germany
| | - G-P Breitbach
- Department of Gynecology, Neunkirchen Clinic, Neunkirchen, Germany
| | - W Janni
- Department of Gynecology, Ulm University Hospital, Ulm, Germany
| | - R Landthaler
- Gynecological Medical Practice of the County Hospital of Krumbach, Krumbach, Germany
| | - A Kohls
- Protestant County Hospital of Ludwigsfelde-Teltow, Ludwigsfelde-Teltow, Germany
| | - D Rezek
- Marien-Hospital Wesel, Wesel, Germany
| | - T Noesselt
- Department of Gynecology of the County Hospital of Hameln, Hameln, Germany
| | - G Fischer
- Mittweida Hospital gGmbH, Mittweida, Germany
| | - S Henschen
- HELIOS Kliniken Schwerin GmbH, Schwerin, Germany
| | - T Praetz
- Caritas-Hospital Bad Mergentheim, Bad Mergentheim, Germany
| | - V Heyl
- Asklepios Paulinen Clinic Wiesbaden, Wiesbaden, Germany
| | - T Kühn
- Department of Gynecology, Esslingen Clinics a.N., Esslingen, Germany
| | - T Krauss
- Department of Gynecology Lippe-Detmold, Lippe-Detmold, Germany
| | - C Thomssen
- Department of Gynecology, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany
| | - A Hohn
- County Hospital of Rendsburg, Rendsburg, Germany
| | - H Tesch
- Oncology Bethanien Frankfurt, Frankfurt, Germany
| | - C Mundhenke
- Department of Gynecology, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Germany
| | - A Hein
- Department of Gynecology, Erlangen University Hospital, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany
| | - C Rauh
- Department of Gynecology, Erlangen University Hospital, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany
| | - C M Bayer
- Department of Gynecology, Erlangen University Hospital, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany
| | - A Jacob
- Novartis Pharma GmbH Nuremberg, Nuremberg, Germany
| | - K Schmidt
- Novartis Pharma GmbH Nuremberg, Nuremberg, Germany
| | | | - S Y Brucker
- Department of Gynecology, University of Tübingen, Tübingen, Germany
| | - S Kümmel
- Breast Unit, Essen Mitte Clinics, Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany
| | - M W Beckmann
- Department of Gynecology, Erlangen University Hospital, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany
| | - D Wallwiener
- Department of Gynecology, University of Tübingen, Tübingen, Germany
| | - P Hadji
- Department of Bone Oncology, Nordwest Hospital, Frankfurt, Germany
| | - P A Fasching
- Department of Gynecology, Erlangen University Hospital, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany
| |
Collapse
|
20
|
Gherasim A, Beck N, Jacob A, Schoettel F, Domis N, De Blay F. Réponse retardée lors d’une exposition aux allergènes dans la chambre d’exposition environnementale (CEE) ALYATEC : différence entre les acariens et le chat. Rev Mal Respir 2019. [DOI: 10.1016/j.rmr.2018.10.160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
21
|
Martinez L, Bloch V, Jacob A, Iskra F, Barreteau H, Razurel A. Sécurisation de la dispensation individuelle et nominative suite à l’implantation d’un automate de dispensation nominative : cartographie des risques a priori au sein d’une pharmacie à usage intérieur. Annales Pharmaceutiques Françaises 2018; 76:473-488. [DOI: 10.1016/j.pharma.2018.05.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2017] [Revised: 05/27/2018] [Accepted: 05/29/2018] [Indexed: 10/28/2022]
|
22
|
Jacob A, Eguzo K, Okwuosa C, Ekanem U. Development and Evaluation of the Use of Local Materials for Medical Simulation in Cancer Education in Nigeria. J Glob Oncol 2018. [DOI: 10.1200/jgo.18.32700] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Background: Lower competence and poorer training of healthcare professionals (HCP) are among the many limitations of cancer control in Nigeria. These manifest as deficiencies in advocacy, screening/diagnostic practices, and patient management. Medical simulation (MS) using models is an effective approach for sustainably improving the competence of HCP. Access to modern, silicone-based simulation models is limited in Nigeria. Cassava starch and papaya fruits are widely available in Nigeria and the tropics, but not widely used for MS. Aim: Study describes the development and evaluation of the use of locally-available materials (cassava starch and immature papaya) as MS models for Papanicolaou test and breast biopsy. Methods: Immature papaya fruits were harvested and using a sharp knife, the stalk was removed to reveal the moist cavity. The space housing the stalk was simulated as the external cervical os ( Fig 1 ). Dried cassava starch was sourced as waste from the pulp. About 100 g of starch was dissolved in a cup using cold water. Boiling water at 100°C was added to the cup and stirred into a thick gel. Gel was poured into a clear polythene bag and shaped into a broad-based dome, to simulate a breast. About 2 cm cuts of ripe plantain were embedded into the gel to simulate breast mass (Fig 2). Clinicians attending a cancer education course were trained on Papanicolaou test using the papaya model, and breast core-biopsy using the gel, respectively. Training also covered clinical breast (CBE) and pelvic examinations (PE). Pre and posttraining surveys with comments evaluating self-reported comfort levels were basis for comparison. Data analysis included descriptive statistics, Wilcoxon signed rank test, χ2 and thematic analysis. Results: Of the 92 course participants (physicians-36, nurses-16), 51 completed the course evaluation forms (response rate=55.4%; 51/92), and average number of years in practice was 8 (±5.2) years. Only 3 physicians had performed Tru-Cut biopsy previously. There was significant improvement in median self-reported comfort level for Tru-Cut (pre=2 {IQR 2-2}, post=4 {4-5}, P < 0.001). Significant improvements were also recorded for median comfort-levels on CBE (4 vs 5, P < 0.01) and PE (4 vs 5, P < 0.01). According to some participants, “it gives a visual view of organs that are not obvious. It is excellent” (#2). “it is very good semblance of a living structure; this goes to enhance hands-on practice” (#41); “simulation helps to build up confidence and improves precision prior to using actual patients” (#19); “excellent! it should be highly recommended for medical training” (#49). Conclusion: Locally-available immature papaya and cassava starch are good MS materials. Their use improved self-reported comfort levels in patient evaluation. Participants recommend widespread use of MS for continuing medical education and undergraduate training. Further studies should evaluate use of cassava starch for breast ultrasound training.[Figure: see text][Figure: see text]
Collapse
Affiliation(s)
- A. Jacob
- Marjorie Bash Foundation, Aba, Nigeria
| | - K. Eguzo
- Marjorie Bash Foundation, Aba, Nigeria
| | | | - U. Ekanem
- Marjorie Bash Foundation, Aba, Nigeria
| |
Collapse
|
23
|
Eguzo K, Jacob A, Okwuosa C, Mbogu F, Owuenyi N, Okoye I, Eguzo C, Ekong E, Okparah M, Sariel P, Oluoha C, Nwankwo G, Nwanyanwu J, Emenike F, Agharanya P, Njoku I, Nworu C, Iwuji C, Nnamani A, Ekanem S, Ezeilo L, Emeonye P. Exploratory Use of Cloud Computing and Social Media for Prostate Cancer Advocacy in Nigeria. J Glob Oncol 2018. [DOI: 10.1200/jgo.18.19900] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Background and context: Prostate cancer is the commonest cancer affecting Nigerian men, with worse outcome compared with men from the developed world. There is limited public awareness about prostate cancer in Nigeria. Oga Blue 4 Prostate Awareness (OB4PA) was created by a consortium of Nigerian nonprofits for prostate cancer advocacy (PCA). Aims: -Design PCA using videos, printed brochure and social media -Implement PCA in five Nigerian states -Evaluate the reach and impact of PCA campaign Program/Policy process: Community-based participatory process, involving the medical community, prostate cancer survivor, and the public was used. Multimedia teaching was used to enhance learning and retention; social media was used to engage groups and individuals. Content development involved iterative consultation among project leaders, medical experts and target audience, often on social media. High-quality teaching videos were recorded in English and Nigerian Pidgin languages. Videos ensured consistency and ease of broadcast. Videos were accessed by OB4PA partners through cloud computing (OneDrive). Facebook was used to promote the campaign, engage local audience, and for Facebook Live presentation. Local health professionals projected the video in appropriate language to audiences in religious and community groups. Brochure detailing clinical features and local service providers was distributed. Audience evaluation was obtained following each interaction. Outcomes: In 6 weeks, 20 presentations were made to 1800 persons. The Facebook Live presentation had 1500 views, reached 9302 people and was shared 107 times. A total of 25 Facebook posts were made, resulting in 628 like, 1908 video views, 160 shares, and reached 14,222 people. Almost all participants had positive feedback on the free and detailed advocacy. Most questions focused on the causes and prevention of prostate cancer, especially on the use of nutritional supplements. What was learned: Cloud computing enabled us to have one presenter; this eliminated the need to find a presenter for each organization. Audience appreciated simplified videos used in explaining the disease process and need for personalized early detection. Facebook live presentation attracted the most reactions on social media, with most comments showing that people liked the intervention. Audience feedback showed that adding advocacy cellphone video by a survivor helped demystify prostate cancer. Having the main presentation video in different file formats and sizes enhanced sharing on social media, as most Nigerians access the Internet on cell phones. Reliable access to projectors was challenging, especially in remote areas. Overall, use of cloud computing and social media were crucial in the success of the PCA project. Lessons from OB4PA informed the design of the current We Can, I Can Conquer Cervical Cancer Awareness project in Nigeria.
Collapse
Affiliation(s)
- K. Eguzo
- University of Saskatchewan - College of Medicine, Saskatoon, Canada
- Marjorie Bash Foundation, Aba, Nigeria
| | - A. Jacob
- Marjorie Bash Foundation, Uyo, Nigeria
| | | | - F. Mbogu
- Health Development Initiative, Aba, Nigeria
| | - N. Owuenyi
- Health Development Initiative, Aba, Nigeria
| | - I. Okoye
- Breast Without Spot, Enugu, Nigeria
| | - C. Eguzo
- Marjorie Bash Foundation, Aba, Nigeria
| | - E. Ekong
- Stand Up To Cancer Foundation, Abuja, Nigeria
| | - M. Okparah
- MAN Project Foundation, Port Harcourt, Nigeria
| | - P. Sariel
- Marjorie Bash Foundation, Jos, Nigeria
| | - C. Oluoha
- Initiative for Public Health Advancement and Research, Umuahia, Nigeria
| | - G. Nwankwo
- Marjorie Bash Foundation, Port Harcourt, Nigeria
| | - J. Nwanyanwu
- Marjorie Bash Foundation, Port Harcourt, Nigeria
| | | | | | - I. Njoku
- Marjorie Bash Foundation, Aba, Nigeria
| | - C. Nworu
- Marjorie Bash Foundation, Aba, Nigeria
| | - C. Iwuji
- University Hospitals of Leicester, Leicester, United Kingdom
| | | | - S. Ekanem
- Stand Up To Cancer Foundation, Lagos, Nigeria
| | | | - P. Emeonye
- Abia State University, Nursing Science, Uturu, Nigeria
| | | |
Collapse
|
24
|
Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I, Kümpfel T, Levy M, Palace J, Ruprecht K, Saiz A, Trebst C, Weinshenker BG, Wildemann B. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 2018; 15:134. [PMID: 29724224 PMCID: PMC5932838 DOI: 10.1186/s12974-018-1144-2] [Citation(s) in RCA: 478] [Impact Index Per Article: 79.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2018] [Accepted: 04/02/2018] [Indexed: 02/11/2023] Open
Abstract
Over the past few years, new-generation cell-based assays have demonstrated a robust association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein (MOG-IgG) with (mostly recurrent) optic neuritis, myelitis and brainstem encephalitis, as well as with acute disseminated encephalomyelitis (ADEM)-like presentations. Most experts now consider MOG-IgG-associated encephalomyelitis (MOG-EM) a disease entity in its own right, immunopathogenetically distinct from both classic multiple sclerosis (MS) and aquaporin-4 (AQP4)-IgG-positive neuromyelitis optica spectrum disorders (NMOSD). Owing to a substantial overlap in clinicoradiological presentation, MOG-EM was often unwittingly misdiagnosed as MS in the past. Accordingly, increasing numbers of patients with suspected or established MS are currently being tested for MOG-IgG. However, screening of large unselected cohorts for rare biomarkers can significantly reduce the positive predictive value of a test. To lessen the hazard of overdiagnosing MOG-EM, which may lead to inappropriate treatment, more selective criteria for MOG-IgG testing are urgently needed. In this paper, we propose indications for MOG-IgG testing based on expert consensus. In addition, we give a list of conditions atypical for MOG-EM ("red flags") that should prompt physicians to challenge a positive MOG-IgG test result. Finally, we provide recommendations regarding assay methodology, specimen sampling and data interpretation.
Collapse
Affiliation(s)
- S Jarius
- Molecular Neuroimmunology Group, Department of Neurology, University Hospital Heidelberg, Im Neuenheimer Feld 350, 69120, Heidelberg, Germany.
| | - F Paul
- Department of Neurology and Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.,NeuroCure Clinical Research Center and Clinical and Experimental Multiple Sclerosis Research Center, Berlin, Germany
| | - O Aktas
- Department of Neurology, University of Düsseldorf, Düsseldorf, Germany
| | - N Asgari
- Department of Neurology, University of Southern Denmark, Odense, Denmark
| | - R C Dale
- Children's Hospital at Westmead, University of Sydney, Sydney, Australia
| | - J de Seze
- Department of Neurology, Hôpital de Hautepierre, Strasbourg Cedex, France
| | - D Franciotta
- IRCCS, National Neurological Institute C. Mondino, Pavia, Italy
| | - K Fujihara
- Department of Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan
| | - A Jacob
- The Walton Centre, Walton Centre NHS Foundation Trust, Liverpool, UK
| | - H J Kim
- Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, South Korea
| | - I Kleiter
- Department of Neurology, Ruhr University Bochum, Bochum, Germany
| | - T Kümpfel
- Institute of Clinical Neuroimmunology, Ludwig Maximilian University, Munich, Germany
| | - M Levy
- Department of Neurology, Johns Hopkins Hospital, Cleveland, USA
| | - J Palace
- Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK
| | - K Ruprecht
- Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - A Saiz
- Service of Neurology, Hospital Clinic, and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain
| | - C Trebst
- Department of Neurology, Hannover Medical School, Hanover, Germany
| | | | - B Wildemann
- Molecular Neuroimmunology Group, Department of Neurology, University Hospital Heidelberg, Im Neuenheimer Feld 350, 69120, Heidelberg, Germany.
| |
Collapse
|
25
|
Tallantyre EC, Whittam DH, Jolles S, Paling D, Constantinesecu C, Robertson NP, Jacob A. Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation. J Neurol 2018; 265:1115-1122. [PMID: 29511864 PMCID: PMC5937879 DOI: 10.1007/s00415-018-8812-0] [Citation(s) in RCA: 42] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2017] [Revised: 02/23/2018] [Accepted: 02/24/2018] [Indexed: 12/20/2022]
Abstract
B-cell depleting anti-CD20 monoclonal antibody therapies are being increasingly used as long-term maintenance therapy for neuroinflammatory disease compared to many non-neurological diseases where they are used as remission-inducing agents. While hypogammaglobulinaemia is known to occur in over half of patients treated with medium to long-term B-cell-depleting therapy (in our cohort IgG 38, IgM 56 and IgA 18%), the risk of infections it poses seems to be under-recognised. Here, we report five cases of serious infections associated with hypogammaglobulinaemia occurring in patients receiving rituximab for neuromyelitis optica spectrum disorders. Sixty-four per cent of the whole cohort of patients studied had hypogammaglobulinemia. We discuss the implications of these cases to the wider use of anti-CD20 therapy in neuroinflammatory disease.
Collapse
Affiliation(s)
- E C Tallantyre
- University Hospital of Wales, Cardiff, UK
- Cardiff University School of Medicine, Cardiff, UK
| | - D H Whittam
- The Walton Centre NHS Trust, Liverpool, L97LJ, UK
- University of Liverpool, Liverpool, UK
| | - S Jolles
- University Hospital of Wales, Cardiff, UK
- Cardiff University School of Medicine, Cardiff, UK
| | - D Paling
- NIHR Sheffield Biomedical Research Centre (Translational Neuroscience), Sheffield, UK
- Royal Hallamshire Hospital, Sheffield, UK
| | | | - N P Robertson
- University Hospital of Wales, Cardiff, UK
- Cardiff University School of Medicine, Cardiff, UK
| | - A Jacob
- The Walton Centre NHS Trust, Liverpool, L97LJ, UK.
- University of Liverpool, Liverpool, UK.
| |
Collapse
|
26
|
Tallantyre EC, Whittam DH, Jolles S, Paling D, Constantinescu C, Robertson NP, Jacob A. Correction to: Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation. J Neurol 2018; 265:1123. [PMID: 29627939 PMCID: PMC5937881 DOI: 10.1007/s00415-018-8833-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Affiliation(s)
- E C Tallantyre
- University Hospital of Wales, Cardiff, UK.,Cardiff University School of Medicine, Cardiff, UK
| | - D H Whittam
- The Walton Centre NHS Trust, Liverpool, L97LJ, UK.,University of Liverpool, Liverpool, UK
| | - S Jolles
- University Hospital of Wales, Cardiff, UK.,Cardiff University School of Medicine, Cardiff, UK
| | - D Paling
- NIHR Sheffield Biomedical Research Centre (Translational Neuroscience), Sheffield, UK.,Royal Hallamshire Hospital, Sheffield, UK
| | | | - N P Robertson
- University Hospital of Wales, Cardiff, UK.,Cardiff University School of Medicine, Cardiff, UK
| | - A Jacob
- The Walton Centre NHS Trust, Liverpool, L97LJ, UK. .,University of Liverpool, Liverpool, UK.
| |
Collapse
|
27
|
Reidel V, Kauschinger J, Hauch RT, Müller-Thomas C, Nadarajah N, Burgkart R, Schmidt B, Hempel D, Jacob A, Slotta-Huspenina J, Höckendorf U, Peschel C, Kern W, Haferlach T, Götze KS, Jilg S, Jost PJ. Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile. Oncotarget 2018; 9:17270-17281. [PMID: 29707107 PMCID: PMC5915115 DOI: 10.18632/oncotarget.24775] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2017] [Accepted: 02/25/2018] [Indexed: 12/03/2022] Open
Abstract
Somatic mutations in genes such as ASXL1, RUNX1, TP53 or EZH2 adversely affect the outcome of patients with myelodysplastic syndromes (MDS). Since selective BCL-2 inhibition is a promising treatment strategy in hematologic malignancies, we tested the therapeutic impact of ABT-199 on MDS patient samples bearing an adverse mutational profile. By gene expression, we found that the level of pro-apoptotic BIM significantly decreased during MDS disease progression in line with an acquired resistance to cell death. Supporting the potential for ABT-199 treatment in MDS, high-risk MDS patient samples specifically underwent cell death in response to ABT-199 even when harbouring mutations in ASXL1, RUNX1, TP53 or EZH2. ABT-199 effectively targeted the stem- and progenitor compartment in advanced MDS harbouring mutations in ASXL1, RUNX1, TP53 or EZH2 and even proved effective in patients harbouring more than one of the defined high-risk mutations. Moreover, we utilized the protein abundance of BCL-2 family members in primary patient samples using flow cytometry as a biomarker to predict ABT-199 treatment response. Our data demonstrate that ABT-199 effectively induces apoptosis in progenitors of high-risk MDS/sAML despite the presence of adverse genetic mutations supporting the notion that pro-apoptotic intervention will hold broad therapeutic potential in high-risk MDS patients with poor prognosis.
Collapse
Affiliation(s)
- Veronika Reidel
- Medizinische Klinik für Hämatologie und Internistische Onkologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
| | - Johanna Kauschinger
- Medizinische Klinik für Hämatologie und Internistische Onkologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
| | - Richard T Hauch
- Medizinische Klinik für Hämatologie und Internistische Onkologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
| | - Catharina Müller-Thomas
- Medizinische Klinik für Hämatologie und Internistische Onkologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
| | | | - Rainer Burgkart
- Klinik für Orthopädie und Sportorthopädie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
| | | | - Dirk Hempel
- Onkologisches Zentrum Donauwörth, Donauwörth, Germany
| | - Anne Jacob
- Medizinische Klinik für Hämatologie und Internistische Onkologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
| | - Julia Slotta-Huspenina
- Institut für Pathologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
| | - Ulrike Höckendorf
- Medizinische Klinik für Hämatologie und Internistische Onkologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
| | - Christian Peschel
- Medizinische Klinik für Hämatologie und Internistische Onkologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.,Deutsche Konsortium für translationale Krebsforschung (DKTK) of the German Cancer Research Center (DKFZ), Heidelberg, Germany
| | | | | | - Katharina S Götze
- Medizinische Klinik für Hämatologie und Internistische Onkologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.,Deutsche Konsortium für translationale Krebsforschung (DKTK) of the German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Stefanie Jilg
- Medizinische Klinik für Hämatologie und Internistische Onkologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
| | - Philipp J Jost
- Medizinische Klinik für Hämatologie und Internistische Onkologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.,Deutsche Konsortium für translationale Krebsforschung (DKTK) of the German Cancer Research Center (DKFZ), Heidelberg, Germany
| |
Collapse
|
28
|
Kley A, Dalla-Pozza R, Fischer M, Heineking B, Jacob A, Schulze-Neick I, Haas N. Pediatric Organ Donation in Bavaria. Thorac Cardiovasc Surg 2018. [DOI: 10.1055/s-0038-1628347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- A. Kley
- Klinikum der Universität München, Kinderkardiologie und Pädiatrische Intensivmedizin, München, Germany
| | - R. Dalla-Pozza
- Klinikum der Universität München, Kinderkardiologie und Pädiatrische Intensivmedizin, München, Germany
| | - M. Fischer
- Klinikum der Universität München, Kinderkardiologie und Pädiatrische Intensivmedizin, München, Germany
| | - B. Heineking
- Klinikum der Universität München, Kinderkardiologie und Pädiatrische Intensivmedizin, München, Germany
| | - A. Jacob
- Klinikum der Universität München, Kinderkardiologie und Pädiatrische Intensivmedizin, München, Germany
| | - I. Schulze-Neick
- Klinikum der Universität München, Kinderkardiologie und Pädiatrische Intensivmedizin, München, Germany
| | - N.A. Haas
- Klinikum der Universität München, Kinderkardiologie und Pädiatrische Intensivmedizin, München, Germany
| |
Collapse
|
29
|
Karim N, Jacob A, Shaukat M, Hua Y, Chiu H, Mehta A, Moore P, Chow A. 59Can high volume tertiary centres with 24/7 device implanting service provide improved efficacy and outcomes compared to a large district general hospital model? Europace 2017. [DOI: 10.1093/europace/eux283.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
30
|
Allin D, David S, Jacob A, Mir N, Giles A, Gibbins N. Use of core biopsy in diagnosing cervical lymphadenopathy: a viable alternative to surgical excisional biopsy of lymph nodes? Ann R Coll Surg Engl 2016; 99:242-244. [PMID: 27917669 DOI: 10.1308/rcsann.2016.0353] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023] Open
Abstract
OBJECTIVES Lymphoma often presents with a neck mass and while fine-needle aspiration cytology may be suggestive, tissue biopsy is required for reliable diagnosis and classification of a lymphoma that is sufficient to deliver the correct treatment for the patient. Traditionally, excisional biopsy of a lymph node has been the standard method of tissue sampling, providing ample tissue for assessment. However, this requires theatre time, and preceding fine-needle aspiration cytology, which may incur a delay. With careful use of tissue, coupled with advances in immunohistochemical and molecular investigative techniques, core biopsy provides a possible alternative to traditional fine-needle aspiration and excisional biopsy. In this study, we aimed to determine the efficacy of diagnosing neck masses. METHOD A retrospective analysis was performed of patients being investigated for a neck mass who were undergoing ultrasound-guided core biopsies of cervical lymph nodes over a 17-month period. The final histology report was scrutinised to assess whether adequate tissue was obtained to allow for full tissue diagnosis. RESULTS Over the 17-month period analysed, 70 patients with cervical lymphadenopathy underwent core biopsy. Of these, 63 (90%) were diagnostic for either lymphoma or other pathology and did not require further tissue sampling. Overall, 19 patients were diagnosed with lymphoma, of which only 1 required further biopsy due to inconclusive initial core biopsy. CONCLUSIONS Current guidelines for investigating lymphomas require that excisional biopsy be performed to obtain ample tissue to allow full nodal architecture assessment and ancillary investigation to reach an accurate histological classification. Within our head and neck multidisciplinary team, however, it is considered that results from core biopsies can be obtained in a more timely fashion and with histological accuracy equal to those of open biopsy. The results obtained demonstrate that core biopsy is an effective tool for investigation. We believe this should be the first-line investigation of choice, as it reduces the need for patients to undergo surgery, is more cost effective and offers a faster diagnosis.
Collapse
Affiliation(s)
- D Allin
- ENT Surgery, Guy's and Saint Thomas' NHS Foundation Trust , London , UK
| | - S David
- Radiology, University Hospital Lewisham , London , Germany
| | - A Jacob
- University Hospital Lewisham , London , UK
| | - N Mir
- Haematology, University Hospital Lewisham , London , UK
| | - A Giles
- Pathology, University Hospital Lewisham , London , UK
| | - N Gibbins
- University Hospital Lewisham , London , UK
| |
Collapse
|
31
|
Abe K, Andreopoulos C, Antonova M, Aoki S, Ariga A, Assylbekov S, Autiero D, Ban S, Barbi M, Barker GJ, Barr G, Bartet-Friburg P, Batkiewicz M, Bay F, Berardi V, Berkman S, Bhadra S, Blondel A, Bolognesi S, Bordoni S, Boyd SB, Brailsford D, Bravar A, Bronner C, Buizza Avanzini M, Calland RG, Campbell T, Cao S, Caravaca Rodríguez J, Cartwright SL, Castillo R, Catanesi MG, Cervera A, Cherdack D, Chikuma N, Christodoulou G, Clifton A, Coleman J, Collazuol G, Coplowe D, Cremonesi L, Dabrowska A, De Rosa G, Dealtry T, Denner PF, Dennis SR, Densham C, Dewhurst D, Di Lodovico F, Di Luise S, Dolan S, Drapier O, Duffy KE, Dumarchez J, Dytman S, Dziewiecki M, Emery-Schrenk S, Ereditato A, Feusels T, Finch AJ, Fiorentini GA, Friend M, Fujii Y, Fukuda D, Fukuda Y, Furmanski AP, Galymov V, Garcia A, Giffin SG, Giganti C, Gizzarelli F, Gonin M, Grant N, Hadley DR, Haegel L, Haigh MD, Hamilton P, Hansen D, Harada J, Hara T, Hartz M, Hasegawa T, Hastings NC, Hayashino T, Hayato Y, Helmer RL, Hierholzer M, Hillairet A, Himmel A, Hiraki T, Hirota S, Hogan M, Holeczek J, Horikawa S, Hosomi F, Huang K, Ichikawa AK, Ieki K, Ikeda M, Imber J, Insler J, Intonti RA, Irvine TJ, Ishida T, Ishii T, Iwai E, Iwamoto K, Izmaylov A, Jacob A, Jamieson B, Jiang M, Johnson S, Jo JH, Jonsson P, Jung CK, Kabirnezhad M, Kaboth AC, Kajita T, Kakuno H, Kameda J, Karlen D, Karpikov I, Katori T, Kearns E, Khabibullin M, Khotjantsev A, Kielczewska D, Kikawa T, Kim H, Kim J, King S, Kisiel J, Knight A, Knox A, Kobayashi T, Koch L, Koga T, Konaka A, Kondo K, Kopylov A, Kormos LL, Korzenev A, Koshio Y, Kropp W, Kudenko Y, Kurjata R, Kutter T, Lagoda J, Lamont I, Larkin E, Lasorak P, Laveder M, Lawe M, Lazos M, Lindner T, Liptak ZJ, Litchfield RP, Li X, Longhin A, Lopez JP, Ludovici L, Lu X, Magaletti L, Mahn K, Malek M, Manly S, Marino AD, Marteau J, Martin JF, Martins P, Martynenko S, Maruyama T, Matveev V, Mavrokoridis K, Ma WY, Mazzucato E, McCarthy M, McCauley N, McFarland KS, McGrew C, Mefodiev A, Metelko C, Mezzetto M, Mijakowski P, Minamino A, Mineev O, Mine S, Missert A, Miura M, Moriyama S, Mueller TA, Murphy S, Myslik J, Nakadaira T, Nakahata M, Nakamura KG, Nakamura K, Nakamura KD, Nakayama S, Nakaya T, Nakayoshi K, Nantais C, Nielsen C, Nirkko M, Nishikawa K, Nishimura Y, Novella P, Nowak J, O'Keeffe HM, Ohta R, Okumura K, Okusawa T, Oryszczak W, Oser SM, Ovsyannikova T, Owen RA, Oyama Y, Palladino V, Palomino JL, Paolone V, Patel ND, Pavin M, Payne D, Perkin JD, Petrov Y, Pickard L, Pickering L, Pinzon Guerra ES, Pistillo C, Popov B, Posiadala-Zezula M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radermacher T, Radicioni E, Ratoff PN, Ravonel M, Rayner MAM, Redij A, Reinherz-Aronis E, Riccio C, Rojas P, Rondio E, Roth S, Rubbia A, Rychter A, Sacco R, Sakashita K, Sánchez F, Sato F, Scantamburlo E, Scholberg K, Schoppmann S, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shah R, Shaikhiev A, Shaker F, Shaw D, Shiozawa M, Shirahige T, Short S, Smy M, Sobczyk JT, Sobel H, Sorel M, Southwell L, Stamoulis P, Steinmann J, Stewart T, Stowell P, Suda Y, Suvorov S, Suzuki A, Suzuki K, Suzuki SY, Suzuki Y, Tacik R, Tada M, Takahashi S, Takeda A, Takeuchi Y, Tanaka HK, Tanaka HA, Terhorst D, Terri R, Thakore T, Thompson LF, Tobayama S, Toki W, Tomura T, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Vacheret A, Vagins M, Vallari Z, Vasseur G, Wachala T, Wakamatsu K, Walter CW, Wark D, Warzycha W, Wascko MO, Weber A, Wendell R, Wilkes RJ, Wilking MJ, Wilkinson C, Wilson JR, Wilson RJ, Yamada Y, Yamamoto K, Yamamoto M, Yanagisawa C, Yano T, Yen S, Yershov N, Yokoyama M, Yoo J, Yoshida K, Yuan T, Yu M, Zalewska A, Zalipska J, Zambelli L, Zaremba K, Ziembicki M, Zimmerman ED, Zito M, Żmuda J. Measurement of Coherent π^{+} Production in Low Energy Neutrino-Carbon Scattering. Phys Rev Lett 2016; 117:192501. [PMID: 27858422 DOI: 10.1103/physrevlett.117.192501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/15/2016] [Indexed: 06/06/2023]
Abstract
We report the first measurement of the flux-averaged cross section for charged current coherent π^{+} production on carbon for neutrino energies less than 1.5 GeV, and with a restriction on the final state phase space volume in the T2K near detector, ND280. Comparisons are made with predictions from the Rein-Sehgal coherent production model and the model by Alvarez-Ruso et al., the latter representing the first implementation of an instance of the new class of microscopic coherent models in a neutrino interaction Monte Carlo event generator. We observe a clear event excess above background, disagreeing with the null results reported by K2K and SciBooNE in a similar neutrino energy region. The measured flux-averaged cross sections are below those predicted by both the Rein-Sehgal and Alvarez-Ruso et al.
Collapse
Affiliation(s)
- K Abe
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - C Andreopoulos
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - M Antonova
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - S Aoki
- Kobe University, Kobe, Japan
| | - A Ariga
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - S Assylbekov
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - D Autiero
- Université de Lyon, Université Claude Bernard Lyon 1, IPN Lyon (IN2P3), Villeurbanne, France
| | - S Ban
- Department of Physics, Kyoto University, Kyoto, Japan
| | - M Barbi
- Department of Physics, University of Regina, Regina, Saskatchewan, Canada
| | - G J Barker
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - G Barr
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - P Bartet-Friburg
- UPMC, Université Paris Diderot, CNRS/IN2P3, Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Paris, France
| | - M Batkiewicz
- H. Niewodniczanski Institute of Nuclear Physics PAN, Cracow, Poland
| | - F Bay
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - V Berardi
- INFN Sezione di Bari and Università e Politecnico di Bari, Dipartimento Interuniversitario di Fisica, Bari, Italy
| | - S Berkman
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - S Bhadra
- Department of Physics and Astronomy, York University, Toronto, Ontario, Canada
| | - A Blondel
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | | | - S Bordoni
- Institut de Fisica d'Altes Energies (IFAE), The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra (Barcelona), Spain
| | - S B Boyd
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - D Brailsford
- Department of Physics, Imperial College London, London, United Kingdom
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - A Bravar
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - C Bronner
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - M Buizza Avanzini
- Ecole Polytechnique, IN2P3-CNRS, Laboratoire Leprince-Ringuet, Palaiseau, France
| | - R G Calland
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - T Campbell
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - S Cao
- Department of Physics, Kyoto University, Kyoto, Japan
| | - J Caravaca Rodríguez
- Institut de Fisica d'Altes Energies (IFAE), The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra (Barcelona), Spain
| | - S L Cartwright
- Department of Physics and Astronomy, University of Sheffield, Sheffield, United Kingdom
| | - R Castillo
- Institut de Fisica d'Altes Energies (IFAE), The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra (Barcelona), Spain
| | - M G Catanesi
- INFN Sezione di Bari and Università e Politecnico di Bari, Dipartimento Interuniversitario di Fisica, Bari, Italy
| | - A Cervera
- IFIC (CSIC & University of Valencia), Valencia, Spain
| | - D Cherdack
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - N Chikuma
- Department of Physics, University of Tokyo, Tokyo, Japan
| | - G Christodoulou
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - A Clifton
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - J Coleman
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - G Collazuol
- Dipartimento di Fisica, INFN Sezione di Padova and Università di Padova, Padova, Italy
| | - D Coplowe
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - L Cremonesi
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - A Dabrowska
- H. Niewodniczanski Institute of Nuclear Physics PAN, Cracow, Poland
| | - G De Rosa
- Dipartimento di Fisica, INFN Sezione di Napoli and Università di Napoli, Napoli, Italy
| | - T Dealtry
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - P F Denner
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - S R Dennis
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - C Densham
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - D Dewhurst
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - F Di Lodovico
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - S Di Luise
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - S Dolan
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - O Drapier
- Ecole Polytechnique, IN2P3-CNRS, Laboratoire Leprince-Ringuet, Palaiseau, France
| | - K E Duffy
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - J Dumarchez
- UPMC, Université Paris Diderot, CNRS/IN2P3, Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Paris, France
| | - S Dytman
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - M Dziewiecki
- Institute of Radioelectronics, Warsaw University of Technology, Warsaw, Poland
| | | | - A Ereditato
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - T Feusels
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - A J Finch
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - G A Fiorentini
- Department of Physics and Astronomy, York University, Toronto, Ontario, Canada
| | - M Friend
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - Y Fujii
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - D Fukuda
- Department of Physics, Okayama University, Okayama, Japan
| | - Y Fukuda
- Department of Physics, Miyagi University of Education, Sendai, Japan
| | - A P Furmanski
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - V Galymov
- Université de Lyon, Université Claude Bernard Lyon 1, IPN Lyon (IN2P3), Villeurbanne, France
| | - A Garcia
- Institut de Fisica d'Altes Energies (IFAE), The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra (Barcelona), Spain
| | - S G Giffin
- Department of Physics, University of Regina, Regina, Saskatchewan, Canada
| | - C Giganti
- UPMC, Université Paris Diderot, CNRS/IN2P3, Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Paris, France
| | | | - M Gonin
- Ecole Polytechnique, IN2P3-CNRS, Laboratoire Leprince-Ringuet, Palaiseau, France
| | - N Grant
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - D R Hadley
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - L Haegel
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - M D Haigh
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - P Hamilton
- Department of Physics, Imperial College London, London, United Kingdom
| | - D Hansen
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - J Harada
- Department of Physics, Osaka City University, Osaka, Japan
| | - T Hara
- Kobe University, Kobe, Japan
| | - M Hartz
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- TRIUMF, Vancouver, British Columbia, Canada
| | - T Hasegawa
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - N C Hastings
- Department of Physics, University of Regina, Regina, Saskatchewan, Canada
| | - T Hayashino
- Department of Physics, Kyoto University, Kyoto, Japan
| | - Y Hayato
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - R L Helmer
- TRIUMF, Vancouver, British Columbia, Canada
| | - M Hierholzer
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - A Hillairet
- Department of Physics and Astronomy, University of Victoria, Victoria, British Columbia, Canada
| | - A Himmel
- Department of Physics, Duke University, Durham, North Carolina, USA
| | - T Hiraki
- Department of Physics, Kyoto University, Kyoto, Japan
| | - S Hirota
- Department of Physics, Kyoto University, Kyoto, Japan
| | - M Hogan
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - J Holeczek
- Institute of Physics, University of Silesia, Katowice, Poland
| | - S Horikawa
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - F Hosomi
- Department of Physics, University of Tokyo, Tokyo, Japan
| | - K Huang
- Department of Physics, Kyoto University, Kyoto, Japan
| | - A K Ichikawa
- Department of Physics, Kyoto University, Kyoto, Japan
| | - K Ieki
- Department of Physics, Kyoto University, Kyoto, Japan
| | - M Ikeda
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - J Imber
- Ecole Polytechnique, IN2P3-CNRS, Laboratoire Leprince-Ringuet, Palaiseau, France
| | - J Insler
- Department of Physics and Astronomy, Louisiana State University, Baton Rouge, Louisiana, USA
| | - R A Intonti
- INFN Sezione di Bari and Università e Politecnico di Bari, Dipartimento Interuniversitario di Fisica, Bari, Italy
| | - T J Irvine
- Institute for Cosmic Ray Research, University of Tokyo, Research Center for Cosmic Neutrinos, Kashiwa, Japan
| | - T Ishida
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - T Ishii
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - E Iwai
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - K Iwamoto
- Department of Physics and Astronomy, University of Rochester, Rochester, New York, USA
| | - A Izmaylov
- IFIC (CSIC & University of Valencia), Valencia, Spain
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - A Jacob
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - B Jamieson
- Department of Physics, University of Winnipeg, Winnipeg, Manitoba, Canada
| | - M Jiang
- Department of Physics, Kyoto University, Kyoto, Japan
| | - S Johnson
- Department of Physics, University of Colorado at Boulder, Boulder, Colorado, USA
| | - J H Jo
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - P Jonsson
- Department of Physics, Imperial College London, London, United Kingdom
| | - C K Jung
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - M Kabirnezhad
- National Centre for Nuclear Research, Warsaw, Poland
| | - A C Kaboth
- Department of Physics, Royal Holloway University of London, Egham, Surrey, United Kingdom
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - T Kajita
- Institute for Cosmic Ray Research, University of Tokyo, Research Center for Cosmic Neutrinos, Kashiwa, Japan
| | - H Kakuno
- Tokyo Metropolitan University, Department of Physics, Tokyo, Japan
| | - J Kameda
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - D Karlen
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, University of Victoria, Victoria, British Columbia, Canada
| | - I Karpikov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - T Katori
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - E Kearns
- Department of Physics, Boston University, Boston, Massachusetts, USA
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - M Khabibullin
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - A Khotjantsev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - D Kielczewska
- Faculty of Physics, University of Warsaw, Warsaw, Poland
| | - T Kikawa
- Department of Physics, Kyoto University, Kyoto, Japan
| | - H Kim
- Department of Physics, Osaka City University, Osaka, Japan
| | - J Kim
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - S King
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - J Kisiel
- Institute of Physics, University of Silesia, Katowice, Poland
| | - A Knight
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - A Knox
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - T Kobayashi
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - L Koch
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - T Koga
- Department of Physics, University of Tokyo, Tokyo, Japan
| | - A Konaka
- TRIUMF, Vancouver, British Columbia, Canada
| | - K Kondo
- Department of Physics, Kyoto University, Kyoto, Japan
| | - A Kopylov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - L L Kormos
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - A Korzenev
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - Y Koshio
- Department of Physics, Okayama University, Okayama, Japan
| | - W Kropp
- Department of Physics and Astronomy, University of California, Irvine, Irvine, California, USA
| | - Y Kudenko
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - R Kurjata
- Institute of Radioelectronics, Warsaw University of Technology, Warsaw, Poland
| | - T Kutter
- Department of Physics and Astronomy, Louisiana State University, Baton Rouge, Louisiana, USA
| | - J Lagoda
- National Centre for Nuclear Research, Warsaw, Poland
| | - I Lamont
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - E Larkin
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - P Lasorak
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - M Laveder
- Dipartimento di Fisica, INFN Sezione di Padova and Università di Padova, Padova, Italy
| | - M Lawe
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - M Lazos
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - T Lindner
- TRIUMF, Vancouver, British Columbia, Canada
| | - Z J Liptak
- Department of Physics, University of Colorado at Boulder, Boulder, Colorado, USA
| | - R P Litchfield
- Department of Physics, Imperial College London, London, United Kingdom
| | - X Li
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - A Longhin
- Dipartimento di Fisica, INFN Sezione di Padova and Università di Padova, Padova, Italy
| | - J P Lopez
- Department of Physics, University of Colorado at Boulder, Boulder, Colorado, USA
| | - L Ludovici
- INFN Sezione di Roma and Università di Roma "La Sapienza", Roma, Italy
| | - X Lu
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - L Magaletti
- INFN Sezione di Bari and Università e Politecnico di Bari, Dipartimento Interuniversitario di Fisica, Bari, Italy
| | - K Mahn
- Department of Physics and Astronomy, Michigan State University, East Lansing, Michigan, USA
| | - M Malek
- Department of Physics and Astronomy, University of Sheffield, Sheffield, United Kingdom
| | - S Manly
- Department of Physics and Astronomy, University of Rochester, Rochester, New York, USA
| | - A D Marino
- Department of Physics, University of Colorado at Boulder, Boulder, Colorado, USA
| | - J Marteau
- Université de Lyon, Université Claude Bernard Lyon 1, IPN Lyon (IN2P3), Villeurbanne, France
| | - J F Martin
- Department of Physics, University of Toronto, Toronto, Ontario, Canada
| | - P Martins
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - S Martynenko
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - T Maruyama
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - V Matveev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - K Mavrokoridis
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - W Y Ma
- Department of Physics, Imperial College London, London, United Kingdom
| | | | - M McCarthy
- Department of Physics and Astronomy, York University, Toronto, Ontario, Canada
| | - N McCauley
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - K S McFarland
- Department of Physics and Astronomy, University of Rochester, Rochester, New York, USA
| | - C McGrew
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - A Mefodiev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - C Metelko
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - M Mezzetto
- Dipartimento di Fisica, INFN Sezione di Padova and Università di Padova, Padova, Italy
| | - P Mijakowski
- National Centre for Nuclear Research, Warsaw, Poland
| | - A Minamino
- Department of Physics, Kyoto University, Kyoto, Japan
| | - O Mineev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - S Mine
- Department of Physics and Astronomy, University of California, Irvine, Irvine, California, USA
| | - A Missert
- Department of Physics, University of Colorado at Boulder, Boulder, Colorado, USA
| | - M Miura
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - S Moriyama
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - Th A Mueller
- Ecole Polytechnique, IN2P3-CNRS, Laboratoire Leprince-Ringuet, Palaiseau, France
| | - S Murphy
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - J Myslik
- Department of Physics and Astronomy, University of Victoria, Victoria, British Columbia, Canada
| | - T Nakadaira
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - M Nakahata
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - K G Nakamura
- Department of Physics, Kyoto University, Kyoto, Japan
| | - K Nakamura
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - K D Nakamura
- Department of Physics, Kyoto University, Kyoto, Japan
| | - S Nakayama
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - T Nakaya
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- Department of Physics, Kyoto University, Kyoto, Japan
| | - K Nakayoshi
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - C Nantais
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - C Nielsen
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - M Nirkko
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - K Nishikawa
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - Y Nishimura
- Institute for Cosmic Ray Research, University of Tokyo, Research Center for Cosmic Neutrinos, Kashiwa, Japan
| | - P Novella
- IFIC (CSIC & University of Valencia), Valencia, Spain
| | - J Nowak
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - H M O'Keeffe
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - R Ohta
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - K Okumura
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- Institute for Cosmic Ray Research, University of Tokyo, Research Center for Cosmic Neutrinos, Kashiwa, Japan
| | - T Okusawa
- Department of Physics, Osaka City University, Osaka, Japan
| | - W Oryszczak
- Faculty of Physics, University of Warsaw, Warsaw, Poland
| | - S M Oser
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - T Ovsyannikova
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - R A Owen
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - Y Oyama
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - V Palladino
- Dipartimento di Fisica, INFN Sezione di Napoli and Università di Napoli, Napoli, Italy
| | - J L Palomino
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - V Paolone
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - N D Patel
- Department of Physics, Kyoto University, Kyoto, Japan
| | - M Pavin
- UPMC, Université Paris Diderot, CNRS/IN2P3, Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Paris, France
| | - D Payne
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - J D Perkin
- Department of Physics and Astronomy, University of Sheffield, Sheffield, United Kingdom
| | - Y Petrov
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - L Pickard
- Department of Physics and Astronomy, University of Sheffield, Sheffield, United Kingdom
| | - L Pickering
- Department of Physics, Imperial College London, London, United Kingdom
| | - E S Pinzon Guerra
- Department of Physics and Astronomy, York University, Toronto, Ontario, Canada
| | - C Pistillo
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - B Popov
- UPMC, Université Paris Diderot, CNRS/IN2P3, Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Paris, France
| | | | | | | | - P Przewlocki
- National Centre for Nuclear Research, Warsaw, Poland
| | - B Quilain
- Department of Physics, Kyoto University, Kyoto, Japan
| | - T Radermacher
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - E Radicioni
- INFN Sezione di Bari and Università e Politecnico di Bari, Dipartimento Interuniversitario di Fisica, Bari, Italy
| | - P N Ratoff
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - M Ravonel
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - M A M Rayner
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - A Redij
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - E Reinherz-Aronis
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - C Riccio
- Dipartimento di Fisica, INFN Sezione di Napoli and Università di Napoli, Napoli, Italy
| | - P Rojas
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - E Rondio
- National Centre for Nuclear Research, Warsaw, Poland
| | - S Roth
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - A Rubbia
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - A Rychter
- Institute of Radioelectronics, Warsaw University of Technology, Warsaw, Poland
| | - R Sacco
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - K Sakashita
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - F Sánchez
- Institut de Fisica d'Altes Energies (IFAE), The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra (Barcelona), Spain
| | - F Sato
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - E Scantamburlo
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - K Scholberg
- Department of Physics, Duke University, Durham, North Carolina, USA
| | - S Schoppmann
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - J Schwehr
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - M Scott
- TRIUMF, Vancouver, British Columbia, Canada
| | - Y Seiya
- Department of Physics, Osaka City University, Osaka, Japan
| | - T Sekiguchi
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - H Sekiya
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - D Sgalaberna
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - R Shah
- Department of Physics, Oxford University, Oxford, United Kingdom
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - A Shaikhiev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - F Shaker
- Department of Physics, University of Winnipeg, Winnipeg, Manitoba, Canada
| | - D Shaw
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - M Shiozawa
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - T Shirahige
- Department of Physics, Okayama University, Okayama, Japan
| | - S Short
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - M Smy
- Department of Physics and Astronomy, University of California, Irvine, Irvine, California, USA
| | - J T Sobczyk
- Faculty of Physics and Astronomy, Wroclaw University, Wroclaw, Poland
| | - H Sobel
- Department of Physics and Astronomy, University of California, Irvine, Irvine, California, USA
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - M Sorel
- IFIC (CSIC & University of Valencia), Valencia, Spain
| | - L Southwell
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - P Stamoulis
- IFIC (CSIC & University of Valencia), Valencia, Spain
| | - J Steinmann
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - T Stewart
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - P Stowell
- Department of Physics and Astronomy, University of Sheffield, Sheffield, United Kingdom
| | - Y Suda
- Department of Physics, University of Tokyo, Tokyo, Japan
| | - S Suvorov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | | | - K Suzuki
- Department of Physics, Kyoto University, Kyoto, Japan
| | - S Y Suzuki
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - Y Suzuki
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - R Tacik
- Department of Physics, University of Regina, Regina, Saskatchewan, Canada
- TRIUMF, Vancouver, British Columbia, Canada
| | - M Tada
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - S Takahashi
- Department of Physics, Kyoto University, Kyoto, Japan
| | - A Takeda
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - Y Takeuchi
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- Kobe University, Kobe, Japan
| | - H K Tanaka
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - H A Tanaka
- Department of Physics, University of Toronto, Toronto, Ontario, Canada
- TRIUMF, Vancouver, British Columbia, Canada
| | - D Terhorst
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - R Terri
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - T Thakore
- Department of Physics and Astronomy, Louisiana State University, Baton Rouge, Louisiana, USA
| | - L F Thompson
- Department of Physics and Astronomy, University of Sheffield, Sheffield, United Kingdom
| | - S Tobayama
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - W Toki
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - T Tomura
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - C Touramanis
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - T Tsukamoto
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - M Tzanov
- Department of Physics and Astronomy, Louisiana State University, Baton Rouge, Louisiana, USA
| | - Y Uchida
- Department of Physics, Imperial College London, London, United Kingdom
| | - A Vacheret
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - M Vagins
- Department of Physics and Astronomy, University of California, Irvine, Irvine, California, USA
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - Z Vallari
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - G Vasseur
- IRFU, CEA Saclay, Gif-sur-Yvette, France
| | - T Wachala
- H. Niewodniczanski Institute of Nuclear Physics PAN, Cracow, Poland
| | - K Wakamatsu
- Department of Physics, Osaka City University, Osaka, Japan
| | - C W Walter
- Department of Physics, Duke University, Durham, North Carolina, USA
| | - D Wark
- Department of Physics, Oxford University, Oxford, United Kingdom
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - W Warzycha
- Faculty of Physics, University of Warsaw, Warsaw, Poland
| | - M O Wascko
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
- Department of Physics, Imperial College London, London, United Kingdom
| | - A Weber
- Department of Physics, Oxford University, Oxford, United Kingdom
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - R Wendell
- Department of Physics, Kyoto University, Kyoto, Japan
| | - R J Wilkes
- Department of Physics, University of Washington, Seattle, Washington, USA
| | - M J Wilking
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - C Wilkinson
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - J R Wilson
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - R J Wilson
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - Y Yamada
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - K Yamamoto
- Department of Physics, Osaka City University, Osaka, Japan
| | - M Yamamoto
- Department of Physics, Kyoto University, Kyoto, Japan
| | - C Yanagisawa
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - T Yano
- Kobe University, Kobe, Japan
| | - S Yen
- TRIUMF, Vancouver, British Columbia, Canada
| | - N Yershov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - M Yokoyama
- Department of Physics, University of Tokyo, Tokyo, Japan
| | - J Yoo
- Department of Physics and Astronomy, Louisiana State University, Baton Rouge, Louisiana, USA
| | - K Yoshida
- Department of Physics, Kyoto University, Kyoto, Japan
| | - T Yuan
- Department of Physics, University of Colorado at Boulder, Boulder, Colorado, USA
| | - M Yu
- Department of Physics and Astronomy, York University, Toronto, Ontario, Canada
| | - A Zalewska
- H. Niewodniczanski Institute of Nuclear Physics PAN, Cracow, Poland
| | - J Zalipska
- National Centre for Nuclear Research, Warsaw, Poland
| | - L Zambelli
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - K Zaremba
- Institute of Radioelectronics, Warsaw University of Technology, Warsaw, Poland
| | - M Ziembicki
- Institute of Radioelectronics, Warsaw University of Technology, Warsaw, Poland
| | - E D Zimmerman
- Department of Physics, University of Colorado at Boulder, Boulder, Colorado, USA
| | - M Zito
- IRFU, CEA Saclay, Gif-sur-Yvette, France
| | - J Żmuda
- Faculty of Physics and Astronomy, Wroclaw University, Wroclaw, Poland
| |
Collapse
|
32
|
O’Sullivan B, Steele T, Ellul M, Kirby E, Duale A, Kier G, Crooks D, Jacob A, Solomon T, Michael B. When should we test for voltage-gated potassium channel complex antibodies? A retrospective case control study. J Clin Neurosci 2016; 33:198-204. [DOI: 10.1016/j.jocn.2016.04.021] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2016] [Revised: 04/12/2016] [Accepted: 04/20/2016] [Indexed: 12/22/2022]
|
33
|
Gopalamurugan AB, Murali K, Jyotsana B, Jacob A, Bashi VV. TAVI for aortic regurgitation - India's first case with Corevalve Evolut R. Indian Heart J 2016; 68 Suppl 2:S4-S7. [PMID: 27751324 PMCID: PMC5067813 DOI: 10.1016/j.ihj.2016.03.022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2016] [Revised: 02/29/2016] [Accepted: 03/22/2016] [Indexed: 11/28/2022] Open
Abstract
Transcatheter Aortic Valve Implantation (TAVI) is a well-described treatment for symptomatic calcific severe aortic stenosis. However, TAVI technology is being increasingly used around the world to treat selected cases of severe aortic regurgitation (AR). One of the main limitations of using TAVI technology for AR is the lack of calcification, which is common in such cases. This makes anchoring of a TAVI prosthesis to the aortic annulus difficult and risks displacement or embolization. However, with the availability of recapturable and repositionable TAVI technologies, these limitations have been overcome to a large extent. This is the first Corevalve Evolut R device that was used in India and the first TAVI to treat AR in India.
Collapse
Affiliation(s)
| | - K Murali
- Head of Department of Interventional Radiology, MIOT Hospitals, Chennai, India
| | - B Jyotsana
- Department of Cardiac Anaesthesiology, MIOT Hospitals, Chennai, India
| | - A Jacob
- Chief of Cardiac Anaesthesiology, ICAAD, India
| | - V V Bashi
- Chief of Department of Cardiothoracic and Vascular Surgery, ICAAD, India
| |
Collapse
|
34
|
Hack CC, Fasching PA, Fehm T, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Wuerstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Fersis N, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesselt T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauß T, Thomssen C, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Jacob A, Schmidt K, Belleville E, Hadji P, Brucker SY, Wallwiener D, Paepke D, Kümmel S, Beckmann MW. Interest in integrative medicine among postmenopausal hormone receptor-positive breast cancer patients receiving letrozole treatment in the EvAluate-TM study. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593261] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
35
|
Moore P, Jackson C, Mutch K, Methley A, Pollard C, Hamid S, Jacob A. Patient-reported outcome measure for neuromyelitis optica: pretesting of preliminary instrument and protocol for further development in accordance with international guidelines. BMJ Open 2016; 6:e011142. [PMID: 27694484 PMCID: PMC5051334 DOI: 10.1136/bmjopen-2016-011142] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/19/2016] [Revised: 03/24/2016] [Accepted: 04/14/2016] [Indexed: 12/18/2022] Open
Abstract
OBJECTIVE This study outlines the development of a patient-reported outcome measure (PROM), an instrument to obtain self-reported health status for neuromyeltis optica (NMO), a disabling neurological condition. DESIGN Development was conducted in accordance with international guidance for PROMs including systematic review of existing literature, item generation guided by qualitative interviews, health-related quality of life conceptual framework and clinical expert panel and cognitive interviews with NMO patients. SETTING Participants were identified through a national NMO clinic in a tertiary NHS neurosciences service. PARTICIPANTS 15 individuals with NMO participated in cognitive interviews requiring review and ranking of proposed PROM items and qualitative feedback on content, layout and response options. RESULTS Participants endorsed the draft instrument as reflecting their experience of the condition and as being easy to understand. Rating and ranking of item relevance and importance reduced the draft instrument from 106 to 48 items. Participant feedback on overlapping items eliminated a further 2 items and resulted in a preliminary instrument of 46 items. As a direct result of participant feedback ordering of the 10 domains was revised, a 4 option Likert scale was employed and a 4-week recall period for impact of symptoms was selected. CONCLUSIONS A 46-item instrument developed in accordance with international PROM development guidelines through literature review, developed by subject matter experts and refined through pretesting examining content validity provides a preliminary measure for assessing patient-report of health status in NMO. Further evaluation is proposed including sensitivity to clinical change, and international contributions to evaluating the measure are encouraged.
Collapse
Affiliation(s)
- P Moore
- Department of Clinical Neuropsychology, The Walton Centre NHS Foundation Trust, Liverpool, UK
| | - C Jackson
- Department of Clinical Neuropsychology, The Walton Centre NHS Foundation Trust, Liverpool, UK Department of Clinical Psychology, University of Liverpool, Liverpool, UK
| | - K Mutch
- Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK
| | - A Methley
- School of Psychological Sciences, University of Manchester, Manchester, UK
| | - C Pollard
- Department of Clinical Neuropsychology, The Walton Centre NHS Foundation Trust, Liverpool, UK
| | - S Hamid
- Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK
| | - A Jacob
- Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK
| |
Collapse
|
36
|
Romo A, Morgan M, Christmas A, Jacob A, Frank H, Dyer J, Spindler H, Walker D. Improving quality of obstetric and neonatal care through midwife
mentoring and simulation training in Bihar, India: mentor knowledge
assessments. Ann Glob Health 2016. [DOI: 10.1016/j.aogh.2016.04.064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
37
|
Stein Y, Jacob A, Goldfinger N, Straussman R, Rotter V. Mutant p53 modulates the signal of hepatocyte growth factor (HGF) to endow cancer cells with drug resistance. Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)61473-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
38
|
Abe K, Andreopoulos C, Antonova M, Aoki S, Ariga A, Assylbekov S, Autiero D, Barbi M, Barker GJ, Barr G, Bartet-Friburg P, Batkiewicz M, Bay F, Berardi V, Berkman S, Bhadra S, Blondel A, Bolognesi S, Bordoni S, Boyd SB, Brailsford D, Bravar A, Bronner C, Buizza Avanzini M, Calland RG, Cao S, Caravaca Rodríguez J, Cartwright SL, Castillo R, Catanesi MG, Cervera A, Cherdack D, Chikuma N, Christodoulou G, Clifton A, Coleman J, Collazuol G, Cremonesi L, Dabrowska A, De Rosa G, Dealtry T, Denner PF, Dennis SR, Densham C, Dewhurst D, Di Lodovico F, Di Luise S, Dolan S, Drapier O, Duffy KE, Dumarchez J, Dytman S, Dziewiecki M, Emery-Schrenk S, Ereditato A, Feusels T, Finch AJ, Fiorentini GA, Friend M, Fujii Y, Fukuda D, Fukuda Y, Furmanski AP, Galymov V, Garcia A, Giffin SG, Giganti C, Gizzarelli F, Gonin M, Grant N, Hadley DR, Haegel L, Haigh MD, Hamilton P, Hansen D, Hara T, Hartz M, Hasegawa T, Hastings NC, Hayashino T, Hayato Y, Helmer RL, Hierholzer M, Hillairet A, Himmel A, Hiraki T, Hirota S, Hogan M, Holeczek J, Horikawa S, Hosomi F, Huang K, Ichikawa AK, Ieki K, Ikeda M, Imber J, Insler J, Intonti RA, Irvine TJ, Ishida T, Ishii T, Iwai E, Iwamoto K, Izmaylov A, Jacob A, Jamieson B, Jiang M, Johnson S, Jo JH, Jonsson P, Jung CK, Kabirnezhad M, Kaboth AC, Kajita T, Kakuno H, Kameda J, Karlen D, Karpikov I, Katori T, Kearns E, Khabibullin M, Khotjantsev A, Kielczewska D, Kikawa T, Kim H, Kim J, King S, Kisiel J, Knight A, Knox A, Kobayashi T, Koch L, Koga T, Konaka A, Kondo K, Kopylov A, Kormos LL, Korzenev A, Koshio Y, Kropp W, Kudenko Y, Kurjata R, Kutter T, Lagoda J, Lamont I, Larkin E, Laveder M, Lawe M, Lazos M, Lindner T, Liptak ZJ, Litchfield RP, Li X, Longhin A, Lopez JP, Ludovici L, Lu X, Magaletti L, Mahn K, Malek M, Manly S, Marino AD, Marteau J, Martin JF, Martins P, Martynenko S, Maruyama T, Matveev V, Mavrokoridis K, Ma WY, Mazzucato E, McCarthy M, McCauley N, McFarland KS, McGrew C, Mefodiev A, Mezzetto M, Mijakowski P, Minamino A, Mineev O, Mine S, Missert A, Miura M, Moriyama S, Mueller TA, Murphy S, Myslik J, Nakadaira T, Nakahata M, Nakamura KG, Nakamura K, Nakamura KD, Nakayama S, Nakaya T, Nakayoshi K, Nantais C, Nielsen C, Nirkko M, Nishikawa K, Nishimura Y, Nowak J, O'Keeffe HM, Ohta R, Okumura K, Okusawa T, Oryszczak W, Oser SM, Ovsyannikova T, Owen RA, Oyama Y, Palladino V, Palomino JL, Paolone V, Patel ND, Pavin M, Payne D, Perkin JD, Petrov Y, Pickard L, Pickering L, Pinzon Guerra ES, Pistillo C, Popov B, Posiadala-Zezula M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radicioni E, Ratoff PN, Ravonel M, Rayner MAM, Redij A, Reinherz-Aronis E, Riccio C, Rojas P, Rondio E, Roth S, Rubbia A, Rychter A, Sacco R, Sakashita K, Sánchez F, Sato F, Scantamburlo E, Scholberg K, Schoppmann S, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shah R, Shaikhiev A, Shaker F, Shaw D, Shiozawa M, Shirahige T, Short S, Smy M, Sobczyk JT, Sorel M, Southwell L, Stamoulis P, Steinmann J, Stewart T, Suda Y, Suvorov S, Suzuki A, Suzuki K, Suzuki SY, Suzuki Y, Tacik R, Tada M, Takahashi S, Takeda A, Takeuchi Y, Tanaka HK, Tanaka HA, Terhorst D, Terri R, Thakore T, Thompson LF, Tobayama S, Toki W, Tomura T, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Vacheret A, Vagins M, Vallari Z, Vasseur G, Wachala T, Wakamatsu K, Walter CW, Wark D, Warzycha W, Wascko MO, Weber A, Wendell R, Wilkes RJ, Wilking MJ, Wilkinson C, Wilson JR, Wilson RJ, Yamada Y, Yamamoto K, Yamamoto M, Yanagisawa C, Yano T, Yen S, Yershov N, Yokoyama M, Yoo J, Yoshida K, Yuan T, Yu M, Zalewska A, Zalipska J, Zambelli L, Zaremba K, Ziembicki M, Zimmerman ED, Zito M, Żmuda J. Measurement of Muon Antineutrino Oscillations with an Accelerator-Produced Off-Axis Beam. Phys Rev Lett 2016; 116:181801. [PMID: 27203315 DOI: 10.1103/physrevlett.116.181801] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/08/2015] [Indexed: 06/05/2023]
Abstract
T2K reports its first measurements of the parameters governing the disappearance of ν[over ¯]_{μ} in an off-axis beam due to flavor change induced by neutrino oscillations. The quasimonochromatic ν[over ¯]_{μ} beam, produced with a peak energy of 0.6 GeV at J-PARC, is observed at the far detector Super-Kamiokande, 295 km away, where the ν[over ¯]_{μ} survival probability is expected to be minimal. Using a data set corresponding to 4.01×10^{20} protons on target, 34 fully contained μ-like events were observed. The best-fit oscillation parameters are sin^{2}(θ[over ¯]_{23})=0.45 and |Δm[over ¯]_{32}^{2}|=2.51×10^{-3} eV^{2} with 68% confidence intervals of 0.38-0.64 and 2.26-2.80×10^{-3} eV^{2}, respectively. These results are in agreement with existing antineutrino parameter measurements and also with the ν_{μ} disappearance parameters measured by T2K.
Collapse
Affiliation(s)
- K Abe
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - C Andreopoulos
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - M Antonova
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - S Aoki
- Kobe University, Kobe, Japan
| | - A Ariga
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - S Assylbekov
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - D Autiero
- Université de Lyon, Université Claude Bernard Lyon 1, IPN Lyon (IN2P3), Villeurbanne, France
| | - M Barbi
- University of Regina, Department of Physics, Regina, Saskatchewan, Canada
| | - G J Barker
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - G Barr
- Oxford University, Department of Physics, Oxford, United Kingdom
| | - P Bartet-Friburg
- UPMC, Université Paris Diderot, CNRS/IN2P3, Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Paris, France
| | - M Batkiewicz
- H. Niewodniczanski Institute of Nuclear Physics PAN, Cracow, Poland
| | - F Bay
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - V Berardi
- INFN Sezione di Bari and Università e Politecnico di Bari, Dipartimento Interuniversitario di Fisica, Bari, Italy
| | - S Berkman
- University of British Columbia, Department of Physics and Astronomy, Vancouver, British Columbia, Canada
| | - S Bhadra
- York University, Department of Physics and Astronomy, Toronto, Ontario, Canada
| | - A Blondel
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | | | - S Bordoni
- Institut de Fisica d'Altes Energies (IFAE), Barcelona Institute of Science and Technology, Campus UAB, Bellaterra (Barcelona), Spain
| | - S B Boyd
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - D Brailsford
- Imperial College London, Department of Physics, London, United Kingdom
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - A Bravar
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - C Bronner
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - M Buizza Avanzini
- Ecole Polytechnique, IN2P3-CNRS, Laboratoire Leprince-Ringuet, Palaiseau, France
| | - R G Calland
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - S Cao
- Kyoto University, Department of Physics, Kyoto, Japan
| | - J Caravaca Rodríguez
- Institut de Fisica d'Altes Energies (IFAE), Barcelona Institute of Science and Technology, Campus UAB, Bellaterra (Barcelona), Spain
| | - S L Cartwright
- University of Sheffield, Department of Physics and Astronomy, Sheffield, United Kingdom
| | - R Castillo
- Institut de Fisica d'Altes Energies (IFAE), Barcelona Institute of Science and Technology, Campus UAB, Bellaterra (Barcelona), Spain
| | - M G Catanesi
- INFN Sezione di Bari and Università e Politecnico di Bari, Dipartimento Interuniversitario di Fisica, Bari, Italy
| | - A Cervera
- IFIC (CSIC and University of Valencia), Valencia, Spain
| | - D Cherdack
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - N Chikuma
- University of Tokyo, Department of Physics, Tokyo, Japan
| | - G Christodoulou
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
| | - A Clifton
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - J Coleman
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
| | - G Collazuol
- INFN Sezione di Padova and Università di Padova, Dipartimento di Fisica, Padova, Italy
| | - L Cremonesi
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - A Dabrowska
- H. Niewodniczanski Institute of Nuclear Physics PAN, Cracow, Poland
| | - G De Rosa
- INFN Sezione di Napoli and Università di Napoli, Dipartimento di Fisica, Napoli, Italy
| | - T Dealtry
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - P F Denner
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - S R Dennis
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
| | - C Densham
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - D Dewhurst
- Oxford University, Department of Physics, Oxford, United Kingdom
| | - F Di Lodovico
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - S Di Luise
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - S Dolan
- Oxford University, Department of Physics, Oxford, United Kingdom
| | - O Drapier
- Ecole Polytechnique, IN2P3-CNRS, Laboratoire Leprince-Ringuet, Palaiseau, France
| | - K E Duffy
- Oxford University, Department of Physics, Oxford, United Kingdom
| | - J Dumarchez
- UPMC, Université Paris Diderot, CNRS/IN2P3, Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Paris, France
| | - S Dytman
- University of Pittsburgh, Department of Physics and Astronomy, Pittsburgh, Pennsylvania, USA
| | - M Dziewiecki
- Warsaw University of Technology, Institute of Radioelectronics, Warsaw, Poland
| | | | - A Ereditato
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - T Feusels
- University of British Columbia, Department of Physics and Astronomy, Vancouver, British Columbia, Canada
| | - A J Finch
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - G A Fiorentini
- York University, Department of Physics and Astronomy, Toronto, Ontario, Canada
| | - M Friend
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - Y Fujii
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - D Fukuda
- Okayama University, Department of Physics, Okayama, Japan
| | - Y Fukuda
- Miyagi University of Education, Department of Physics, Sendai, Japan
| | - A P Furmanski
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - V Galymov
- Université de Lyon, Université Claude Bernard Lyon 1, IPN Lyon (IN2P3), Villeurbanne, France
| | - A Garcia
- Institut de Fisica d'Altes Energies (IFAE), Barcelona Institute of Science and Technology, Campus UAB, Bellaterra (Barcelona), Spain
| | - S G Giffin
- University of Regina, Department of Physics, Regina, Saskatchewan, Canada
| | - C Giganti
- UPMC, Université Paris Diderot, CNRS/IN2P3, Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Paris, France
| | | | - M Gonin
- Ecole Polytechnique, IN2P3-CNRS, Laboratoire Leprince-Ringuet, Palaiseau, France
| | - N Grant
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - D R Hadley
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - L Haegel
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - M D Haigh
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - P Hamilton
- Imperial College London, Department of Physics, London, United Kingdom
| | - D Hansen
- University of Pittsburgh, Department of Physics and Astronomy, Pittsburgh, Pennsylvania, USA
| | - T Hara
- Kobe University, Kobe, Japan
| | - M Hartz
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- TRIUMF, Vancouver, British Columbia, Canada
| | - T Hasegawa
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - N C Hastings
- University of Regina, Department of Physics, Regina, Saskatchewan, Canada
| | - T Hayashino
- Kyoto University, Department of Physics, Kyoto, Japan
| | - Y Hayato
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - R L Helmer
- TRIUMF, Vancouver, British Columbia, Canada
| | - M Hierholzer
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - A Hillairet
- University of Victoria, Department of Physics and Astronomy, Victoria, British Columbia, Canada
| | - A Himmel
- Duke University, Department of Physics, Durham, North Carolina, USA
| | - T Hiraki
- Kyoto University, Department of Physics, Kyoto, Japan
| | - S Hirota
- Kyoto University, Department of Physics, Kyoto, Japan
| | - M Hogan
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - J Holeczek
- University of Silesia, Institute of Physics, Katowice, Poland
| | - S Horikawa
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - F Hosomi
- University of Tokyo, Department of Physics, Tokyo, Japan
| | - K Huang
- Kyoto University, Department of Physics, Kyoto, Japan
| | - A K Ichikawa
- Kyoto University, Department of Physics, Kyoto, Japan
| | - K Ieki
- Kyoto University, Department of Physics, Kyoto, Japan
| | - M Ikeda
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - J Imber
- Ecole Polytechnique, IN2P3-CNRS, Laboratoire Leprince-Ringuet, Palaiseau, France
| | - J Insler
- Louisiana State University, Department of Physics and Astronomy, Baton Rouge, Louisiana, USA
| | - R A Intonti
- INFN Sezione di Bari and Università e Politecnico di Bari, Dipartimento Interuniversitario di Fisica, Bari, Italy
| | - T J Irvine
- University of Tokyo, Institute for Cosmic Ray Research, Research Center for Cosmic Neutrinos, Kashiwa, Japan
| | - T Ishida
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - T Ishii
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - E Iwai
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - K Iwamoto
- University of Rochester, Department of Physics and Astronomy, Rochester, New York, USA
| | - A Izmaylov
- IFIC (CSIC and University of Valencia), Valencia, Spain
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - A Jacob
- Oxford University, Department of Physics, Oxford, United Kingdom
| | - B Jamieson
- University of Winnipeg, Department of Physics, Winnipeg, Manitoba, Canada
| | - M Jiang
- Kyoto University, Department of Physics, Kyoto, Japan
| | - S Johnson
- University of Colorado at Boulder, Department of Physics, Boulder, Colorado, USA
| | - J H Jo
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - P Jonsson
- Imperial College London, Department of Physics, London, United Kingdom
| | - C K Jung
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - M Kabirnezhad
- National Centre for Nuclear Research, Warsaw, Poland
| | - A C Kaboth
- Royal Holloway University of London, Department of Physics, Egham, Surrey, United Kingdom
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - T Kajita
- University of Tokyo, Institute for Cosmic Ray Research, Research Center for Cosmic Neutrinos, Kashiwa, Japan
| | - H Kakuno
- Tokyo Metropolitan University, Department of Physics, Tokyo, Japan
| | - J Kameda
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - D Karlen
- TRIUMF, Vancouver, British Columbia, Canada
- University of Victoria, Department of Physics and Astronomy, Victoria, British Columbia, Canada
| | - I Karpikov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - T Katori
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - E Kearns
- Boston University, Department of Physics, Boston, Massachusetts, USA
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - M Khabibullin
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - A Khotjantsev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - D Kielczewska
- University of Warsaw, Faculty of Physics, Warsaw, Poland
| | - T Kikawa
- Kyoto University, Department of Physics, Kyoto, Japan
| | - H Kim
- Osaka City University, Department of Physics, Osaka, Japan
| | - J Kim
- University of British Columbia, Department of Physics and Astronomy, Vancouver, British Columbia, Canada
| | - S King
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - J Kisiel
- University of Silesia, Institute of Physics, Katowice, Poland
| | - A Knight
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - A Knox
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - T Kobayashi
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - L Koch
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - T Koga
- University of Tokyo, Department of Physics, Tokyo, Japan
| | - A Konaka
- TRIUMF, Vancouver, British Columbia, Canada
| | - K Kondo
- Kyoto University, Department of Physics, Kyoto, Japan
| | - A Kopylov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - L L Kormos
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - A Korzenev
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - Y Koshio
- Okayama University, Department of Physics, Okayama, Japan
| | - W Kropp
- University of California, Irvine, Department of Physics and Astronomy, Irvine, California, USA
| | - Y Kudenko
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - R Kurjata
- Warsaw University of Technology, Institute of Radioelectronics, Warsaw, Poland
| | - T Kutter
- Louisiana State University, Department of Physics and Astronomy, Baton Rouge, Louisiana, USA
| | - J Lagoda
- National Centre for Nuclear Research, Warsaw, Poland
| | - I Lamont
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - E Larkin
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - M Laveder
- INFN Sezione di Padova and Università di Padova, Dipartimento di Fisica, Padova, Italy
| | - M Lawe
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - M Lazos
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
| | - T Lindner
- TRIUMF, Vancouver, British Columbia, Canada
| | - Z J Liptak
- University of Colorado at Boulder, Department of Physics, Boulder, Colorado, USA
| | - R P Litchfield
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - X Li
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - A Longhin
- INFN Sezione di Padova and Università di Padova, Dipartimento di Fisica, Padova, Italy
| | - J P Lopez
- University of Colorado at Boulder, Department of Physics, Boulder, Colorado, USA
| | - L Ludovici
- INFN Sezione di Roma and Università di Roma "La Sapienza," Roma, Italy
| | - X Lu
- Oxford University, Department of Physics, Oxford, United Kingdom
| | - L Magaletti
- INFN Sezione di Bari and Università e Politecnico di Bari, Dipartimento Interuniversitario di Fisica, Bari, Italy
| | - K Mahn
- Michigan State University, Department of Physics and Astronomy, East Lansing, Michigan, USA
| | - M Malek
- University of Sheffield, Department of Physics and Astronomy, Sheffield, United Kingdom
| | - S Manly
- University of Rochester, Department of Physics and Astronomy, Rochester, New York, USA
| | - A D Marino
- University of Colorado at Boulder, Department of Physics, Boulder, Colorado, USA
| | - J Marteau
- Université de Lyon, Université Claude Bernard Lyon 1, IPN Lyon (IN2P3), Villeurbanne, France
| | - J F Martin
- University of Toronto, Department of Physics, Toronto, Ontario, Canada
| | - P Martins
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - S Martynenko
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - T Maruyama
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - V Matveev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - K Mavrokoridis
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
| | - W Y Ma
- Imperial College London, Department of Physics, London, United Kingdom
| | | | - M McCarthy
- York University, Department of Physics and Astronomy, Toronto, Ontario, Canada
| | - N McCauley
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
| | - K S McFarland
- University of Rochester, Department of Physics and Astronomy, Rochester, New York, USA
| | - C McGrew
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - A Mefodiev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - M Mezzetto
- INFN Sezione di Padova and Università di Padova, Dipartimento di Fisica, Padova, Italy
| | - P Mijakowski
- National Centre for Nuclear Research, Warsaw, Poland
| | - A Minamino
- Kyoto University, Department of Physics, Kyoto, Japan
| | - O Mineev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - S Mine
- University of California, Irvine, Department of Physics and Astronomy, Irvine, California, USA
| | - A Missert
- University of Colorado at Boulder, Department of Physics, Boulder, Colorado, USA
| | - M Miura
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - S Moriyama
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - Th A Mueller
- Ecole Polytechnique, IN2P3-CNRS, Laboratoire Leprince-Ringuet, Palaiseau, France
| | - S Murphy
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - J Myslik
- University of Victoria, Department of Physics and Astronomy, Victoria, British Columbia, Canada
| | - T Nakadaira
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - M Nakahata
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - K G Nakamura
- Kyoto University, Department of Physics, Kyoto, Japan
| | - K Nakamura
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - K D Nakamura
- Kyoto University, Department of Physics, Kyoto, Japan
| | - S Nakayama
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - T Nakaya
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- Kyoto University, Department of Physics, Kyoto, Japan
| | - K Nakayoshi
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - C Nantais
- University of British Columbia, Department of Physics and Astronomy, Vancouver, British Columbia, Canada
| | - C Nielsen
- University of British Columbia, Department of Physics and Astronomy, Vancouver, British Columbia, Canada
| | - M Nirkko
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - K Nishikawa
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - Y Nishimura
- University of Tokyo, Institute for Cosmic Ray Research, Research Center for Cosmic Neutrinos, Kashiwa, Japan
| | - J Nowak
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - H M O'Keeffe
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - R Ohta
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - K Okumura
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- University of Tokyo, Institute for Cosmic Ray Research, Research Center for Cosmic Neutrinos, Kashiwa, Japan
| | - T Okusawa
- Osaka City University, Department of Physics, Osaka, Japan
| | - W Oryszczak
- University of Warsaw, Faculty of Physics, Warsaw, Poland
| | - S M Oser
- University of British Columbia, Department of Physics and Astronomy, Vancouver, British Columbia, Canada
| | - T Ovsyannikova
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - R A Owen
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - Y Oyama
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - V Palladino
- INFN Sezione di Napoli and Università di Napoli, Dipartimento di Fisica, Napoli, Italy
| | - J L Palomino
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - V Paolone
- University of Pittsburgh, Department of Physics and Astronomy, Pittsburgh, Pennsylvania, USA
| | - N D Patel
- Kyoto University, Department of Physics, Kyoto, Japan
| | - M Pavin
- UPMC, Université Paris Diderot, CNRS/IN2P3, Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Paris, France
| | - D Payne
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
| | - J D Perkin
- University of Sheffield, Department of Physics and Astronomy, Sheffield, United Kingdom
| | - Y Petrov
- University of British Columbia, Department of Physics and Astronomy, Vancouver, British Columbia, Canada
| | - L Pickard
- University of Sheffield, Department of Physics and Astronomy, Sheffield, United Kingdom
| | - L Pickering
- Imperial College London, Department of Physics, London, United Kingdom
| | - E S Pinzon Guerra
- York University, Department of Physics and Astronomy, Toronto, Ontario, Canada
| | - C Pistillo
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - B Popov
- UPMC, Université Paris Diderot, CNRS/IN2P3, Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Paris, France
| | | | | | | | - P Przewlocki
- National Centre for Nuclear Research, Warsaw, Poland
| | - B Quilain
- Kyoto University, Department of Physics, Kyoto, Japan
| | - E Radicioni
- INFN Sezione di Bari and Università e Politecnico di Bari, Dipartimento Interuniversitario di Fisica, Bari, Italy
| | - P N Ratoff
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - M Ravonel
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - M A M Rayner
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - A Redij
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - E Reinherz-Aronis
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - C Riccio
- INFN Sezione di Napoli and Università di Napoli, Dipartimento di Fisica, Napoli, Italy
| | - P Rojas
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - E Rondio
- National Centre for Nuclear Research, Warsaw, Poland
| | - S Roth
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - A Rubbia
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - A Rychter
- Warsaw University of Technology, Institute of Radioelectronics, Warsaw, Poland
| | - R Sacco
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - K Sakashita
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - F Sánchez
- Institut de Fisica d'Altes Energies (IFAE), Barcelona Institute of Science and Technology, Campus UAB, Bellaterra (Barcelona), Spain
| | - F Sato
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - E Scantamburlo
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - K Scholberg
- Duke University, Department of Physics, Durham, North Carolina, USA
| | - S Schoppmann
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - J Schwehr
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - M Scott
- TRIUMF, Vancouver, British Columbia, Canada
| | - Y Seiya
- Osaka City University, Department of Physics, Osaka, Japan
| | - T Sekiguchi
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - H Sekiya
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - D Sgalaberna
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - R Shah
- Oxford University, Department of Physics, Oxford, United Kingdom
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - A Shaikhiev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - F Shaker
- University of Winnipeg, Department of Physics, Winnipeg, Manitoba, Canada
| | - D Shaw
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - M Shiozawa
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - T Shirahige
- Okayama University, Department of Physics, Okayama, Japan
| | - S Short
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - M Smy
- University of California, Irvine, Department of Physics and Astronomy, Irvine, California, USA
| | - J T Sobczyk
- Wroclaw University, Faculty of Physics and Astronomy, Wroclaw, Poland
| | - M Sorel
- IFIC (CSIC and University of Valencia), Valencia, Spain
| | - L Southwell
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - P Stamoulis
- IFIC (CSIC and University of Valencia), Valencia, Spain
| | - J Steinmann
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - T Stewart
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - Y Suda
- University of Tokyo, Department of Physics, Tokyo, Japan
| | - S Suvorov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | | | - K Suzuki
- Kyoto University, Department of Physics, Kyoto, Japan
| | - S Y Suzuki
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - Y Suzuki
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - R Tacik
- University of Regina, Department of Physics, Regina, Saskatchewan, Canada
- TRIUMF, Vancouver, British Columbia, Canada
| | - M Tada
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - S Takahashi
- Kyoto University, Department of Physics, Kyoto, Japan
| | - A Takeda
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - Y Takeuchi
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- Kobe University, Kobe, Japan
| | - H K Tanaka
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - H A Tanaka
- University of Toronto, Department of Physics, Toronto, Ontario, Canada
- TRIUMF, Vancouver, British Columbia, Canada
| | - D Terhorst
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - R Terri
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - T Thakore
- Louisiana State University, Department of Physics and Astronomy, Baton Rouge, Louisiana, USA
| | - L F Thompson
- University of Sheffield, Department of Physics and Astronomy, Sheffield, United Kingdom
| | - S Tobayama
- University of British Columbia, Department of Physics and Astronomy, Vancouver, British Columbia, Canada
| | - W Toki
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - T Tomura
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - C Touramanis
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
| | - T Tsukamoto
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - M Tzanov
- Louisiana State University, Department of Physics and Astronomy, Baton Rouge, Louisiana, USA
| | - Y Uchida
- Imperial College London, Department of Physics, London, United Kingdom
| | - A Vacheret
- Oxford University, Department of Physics, Oxford, United Kingdom
| | - M Vagins
- University of California, Irvine, Department of Physics and Astronomy, Irvine, California, USA
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - Z Vallari
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - G Vasseur
- IRFU, CEA Saclay, Gif-sur-Yvette, France
| | - T Wachala
- H. Niewodniczanski Institute of Nuclear Physics PAN, Cracow, Poland
| | - K Wakamatsu
- Osaka City University, Department of Physics, Osaka, Japan
| | - C W Walter
- Duke University, Department of Physics, Durham, North Carolina, USA
| | - D Wark
- Oxford University, Department of Physics, Oxford, United Kingdom
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - W Warzycha
- University of Warsaw, Faculty of Physics, Warsaw, Poland
| | - M O Wascko
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
- Imperial College London, Department of Physics, London, United Kingdom
| | - A Weber
- Oxford University, Department of Physics, Oxford, United Kingdom
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - R Wendell
- Kyoto University, Department of Physics, Kyoto, Japan
| | - R J Wilkes
- University of Washington, Department of Physics, Seattle, Washington, USA
| | - M J Wilking
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - C Wilkinson
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - J R Wilson
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - R J Wilson
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - Y Yamada
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - K Yamamoto
- Osaka City University, Department of Physics, Osaka, Japan
| | - M Yamamoto
- Kyoto University, Department of Physics, Kyoto, Japan
| | - C Yanagisawa
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - T Yano
- Kobe University, Kobe, Japan
| | - S Yen
- TRIUMF, Vancouver, British Columbia, Canada
| | - N Yershov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - M Yokoyama
- University of Tokyo, Department of Physics, Tokyo, Japan
| | - J Yoo
- Louisiana State University, Department of Physics and Astronomy, Baton Rouge, Louisiana, USA
| | - K Yoshida
- Kyoto University, Department of Physics, Kyoto, Japan
| | - T Yuan
- University of Colorado at Boulder, Department of Physics, Boulder, Colorado, USA
| | - M Yu
- York University, Department of Physics and Astronomy, Toronto, Ontario, Canada
| | - A Zalewska
- H. Niewodniczanski Institute of Nuclear Physics PAN, Cracow, Poland
| | - J Zalipska
- National Centre for Nuclear Research, Warsaw, Poland
| | - L Zambelli
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - K Zaremba
- Warsaw University of Technology, Institute of Radioelectronics, Warsaw, Poland
| | - M Ziembicki
- Warsaw University of Technology, Institute of Radioelectronics, Warsaw, Poland
| | - E D Zimmerman
- University of Colorado at Boulder, Department of Physics, Boulder, Colorado, USA
| | - M Zito
- IRFU, CEA Saclay, Gif-sur-Yvette, France
| | - J Żmuda
- Wroclaw University, Faculty of Physics and Astronomy, Wroclaw, Poland
| |
Collapse
|
39
|
Mercado-Pimentel ME, Igarashi S, Dunn AM, Behbahani M, Miller C, Read CM, Jacob A. The Novel Small Molecule Inhibitor, OSU-T315, Suppresses Vestibular Schwannoma and Meningioma Growth by Inhibiting PDK2 Function in the AKT Pathway Activation. Austin J Med Oncol 2016; 3:1025. [PMID: 27642646 PMCID: PMC5024787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Activation of PKB/AKT signaling, which requires PDK1 and PDK2 function, drives Vestibular Schwannoma (VS) and meningioma growth. PDK2 function is defined as a molecule that phosphorylates AKT-Ser473. Integrin-Linked Kinase (ILK) functions as PDK2 in PKB/AKT activation in many cancers; therefore, we hypothesized that OSU-T315, a small molecule ILK inhibitor, will inhibit the ILK-PDK2 function in PKB/AKT signaling activation in VS and meningioma cell growth. OSU-T315 decreased cell viability at IC50 < 2μM in VS (HEI193) and meningioma (Ben-Men-1) cell lines, in primary cells at < 3.5μM, while in normal primary Schwann cells at 7.1μM. OSU-T315 inhibits AKT signaling by decreasing phosphorylation at AKT-Ser473, AKT-Thr308, ILK-Ser246 and ILK-Thr173. In addition, OSU-T315 affected the phosphorylation or expression levels of AKT downstream proliferation effectors as well as autophagy markers. Flow cytometry shows that OSU-T315 increased the percentage of cells arrested at G2/M for both, HEI193 (39.99%) and Ben-Men-1 (26.96%) cells, compared to controls (21.54%, 8.47%). Two hours of OSU-T315 treatment increased cell death in both cell lines (34.3%, 9.1%) versus untreated (12.1%, 8.1%). Though longer exposure increased cell death in Ben-Men-1, TUNEL assays showed that OSU-T315 does not induce apoptosis. OSU-T315 was primarily cytotoxic for HEI193 and Ben-Men-1 inducing a dysregulated autophagy. Our studies suggest that OSU-T315 has translational potential as a chemotherapeutic agent against VS and meningioma.
Collapse
Affiliation(s)
- M E Mercado-Pimentel
- Ear Institute, University of Arizona, USA; Department of Otolaryngology, University of Arizona, USA; Arizona Cancer Center, University of Arizona, USA
| | - S Igarashi
- Ear Institute, University of Arizona, USA; Department of Otolaryngology, University of Arizona, USA
| | - A M Dunn
- Ear Institute, University of Arizona, USA; Department of Otolaryngology, University of Arizona, USA
| | - M Behbahani
- Ear Institute, University of Arizona, USA; Department of Otolaryngology, University of Arizona, USA
| | - C Miller
- Ear Institute, University of Arizona, USA; Department of Otolaryngology, University of Arizona, USA
| | - C M Read
- Ear Institute, University of Arizona, USA
| | - A Jacob
- Ear Institute, University of Arizona, USA; Department of Otolaryngology, University of Arizona, USA; Arizona Cancer Center, University of Arizona, USA; BIO5 Institute, University of Arizona, USA
| |
Collapse
|
40
|
Ellis RJB, Mbizvo GK, Jacob A, Doran M, Larner AJ. Relapsing polychondritis complicated by cognitive dysfunction: two distinct clinical phenotypes? Int J Neurosci 2016; 127:124-134. [DOI: 10.3109/00207454.2016.1151880] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Affiliation(s)
- R. J. B. Ellis
- Neurology Department, The Walton Centre for Neurology and Neurosurgery, Liverpool, UK
| | - G. K. Mbizvo
- Neurology Department, The Walton Centre for Neurology and Neurosurgery, Liverpool, UK
| | - A. Jacob
- Neurology Department, The Walton Centre for Neurology and Neurosurgery, Liverpool, UK
| | - M. Doran
- Neurology Department, The Walton Centre for Neurology and Neurosurgery, Liverpool, UK
| | - A. J. Larner
- Neurology Department, The Walton Centre for Neurology and Neurosurgery, Liverpool, UK
| |
Collapse
|
41
|
Schubert S, Opgen-Rhein B, Haverkämper G, zu Knyphausen E, Weise A, Jacob A, Rompel O, Schranz D, Müller G, Schmidt F, Kästner M, Udink ten Cate F, Wagner R, Ruf B, Pickardt T, Messroghli D. Myocarditis in Paediatric Patients: Age and Gender Are Influencing Incidence, Severity, and Clinical Course: Initial Data Analysis from the German Multi-Centre Registry (“MYKKE”). Thorac Cardiovasc Surg 2016. [DOI: 10.1055/s-0036-1571882] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
42
|
Voelklein MA, Jacob A, O' Shea R, Murphy JD. Assessment of increasing loading rate on two-stage digestion of food waste. Bioresour Technol 2016; 202:172-180. [PMID: 26708485 DOI: 10.1016/j.biortech.2015.12.001] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/07/2015] [Revised: 11/30/2015] [Accepted: 12/09/2015] [Indexed: 06/05/2023]
Abstract
A two-stage food waste digestion system involved a first stage hydrolysis reactor followed by a second stage methanogenic reactor. Organic loading rates (OLR) were increased from 6 to 15 g VS L(-1) d(-1) in the hydrolysis reactor and from 2 to 5 g VS L(-1) d(-1) in the methanogenic reactor. The retention time was fixed at 4 days (hydrolysis reactor) and 12 days (methane reactor). A single-stage digester was subjected to similar loading rates as the methanogenic reactor at 16 days retention. Increased OLR resulted in higher quantities of liquid fermentation products from the first stage hydrolysis reactor. Solubilisation of chemical oxygen demand peaked at 47% at the maximum loading. However, enhanced hydrolysis yields had no significant impact on the specific methane yields. The two-stage system increased methane yields up to 23% and enriched methane content by an average of 14% to levels of 71%.
Collapse
Affiliation(s)
- M A Voelklein
- MaREI Centre, Environmental Research Institute (ERI), University College Cork (UCC), Ireland; School of Engineering, UCC, Ireland
| | - A Jacob
- MaREI Centre, Environmental Research Institute (ERI), University College Cork (UCC), Ireland; School of Engineering, UCC, Ireland
| | - R O' Shea
- MaREI Centre, Environmental Research Institute (ERI), University College Cork (UCC), Ireland; School of Engineering, UCC, Ireland
| | - J D Murphy
- MaREI Centre, Environmental Research Institute (ERI), University College Cork (UCC), Ireland; School of Engineering, UCC, Ireland.
| |
Collapse
|
43
|
Abe K, Adam J, Aihara H, Andreopoulos C, Aoki S, Ariga A, Assylbekov S, Autiero D, Barbi M, Barker G, Barr G, Bartet-Friburg P, Bass M, Batkiewicz M, Bay F, Berardi V, Berger B, Berkman S, Bhadra S, Blaszczyk F, Blondel A, Bolognesi S, Bordoni S, Boyd S, Brailsford D, Bravar A, Bronner C, Buchanan N, Calland R, Caravaca Rodríguez J, Cartwright S, Castillo R, Catanesi M, Cervera A, Cherdack D, Chikuma N, Christodoulou G, Clifton A, Coleman J, Coleman S, Collazuol G, Connolly K, Cremonesi L, Dabrowska A, Das R, Davis S, de Perio P, De Rosa G, Dealtry T, Dennis S, Densham C, Dewhurst D, Di Lodovico F, Di Luise S, Dolan S, Drapier O, Duffy K, Dumarchez J, Dytman S, Dziewiecki M, Emery-Schrenk S, Ereditato A, Escudero L, Feusels T, Finch A, Fiorentini G, Friend M, Fujii Y, Fukuda Y, Furmanski A, Galymov V, Garcia A, Giffin S, Giganti C, Gilje K, Goeldi D, Golan T, Gonin M, Grant N, Gudin D, Hadley D, Haegel L, Haesler A, Haigh M, Hamilton P, Hansen D, Hara T, Hartz M, Hasegawa T, Hastings N, Hayashino T, Hayato Y, Helmer R, Hierholzer M, Hignight J, Hillairet A, Himmel A, Hiraki T, Hirota S, Holeczek J, Horikawa S, Hosomi F, Huang K, Ichikawa A, Ieki K, Ieva M, Ikeda M, Imber J, Insler J, Irvine T, Ishida T, Ishii T, Iwai E, Iwamoto K, Iyogi K, Izmaylov A, Jacob A, Jamieson B, Jiang M, Johnson S, Jo J, Jonsson P, Jung C, Kabirnezhad M, Kaboth A, Kajita T, Kakuno H, Kameda J, Kanazawa Y, Karlen D, Karpikov I, Katori T, Kearns E, Khabibullin M, Khotjantsev A, Kielczewska D, Kikawa T, Kilinski A, Kim J, King S, Kisiel J, Kitching P, Kobayashi T, Koch L, Koga T, Kolaceke A, Konaka A, Kopylov A, Kormos L, Korzenev A, Koshio Y, Kropp W, Kubo H, Kudenko Y, Kurjata R, Kutter T, Lagoda J, Lamont I, Larkin E, Laveder M, Lawe M, Lazos M, Lindner T, Lister C, Litchfield R, Longhin A, Lopez J, Ludovici L, Magaletti L, Mahn K, Malek M, Manly S, Marino A, Marteau J, Martin J, Martins P, Martynenko S, Maruyama T, Matveev V, Mavrokoridis K, Mazzucato E, McCarthy M, McCauley N, McFarland K, McGrew C, Mefodiev A, Metelko C, Mezzetto M, Mijakowski P, Miller C, Minamino A, Mineev O, Mine S, Missert A, Miura M, Moriyama S, Mueller T, Murakami A, Murdoch M, Murphy S, Myslik J, Nakadaira T, Nakahata M, Nakamura K, Nakamura K, Nakayama S, Nakaya T, Nakayoshi K, Nantais C, Nielsen C, Nirkko M, Nishikawa K, Nishimura Y, Nowak J, O’Keeffe H, Ohta R, Okumura K, Okusawa T, Oryszczak W, Oser S, Ovsyannikova T, Owen R, Oyama Y, Palladino V, Palomino J, Paolone V, Payne D, Perevozchikov O, Perkin J, Petrov Y, Pickard L, Pinzon Guerra E, Pistillo C, Plonski P, Poplawska E, Popov B, Posiadala-Zezula M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radicioni E, Ratoff P, Ravonel M, Rayner M, Redij A, Reeves M, Reinherz-Aronis E, Riccio C, Rodrigues P, Rojas P, Rondio E, Roth S, Rubbia A, Ruterbories D, Rychter A, Sacco R, Sakashita K, Sánchez F, Sato F, Scantamburlo E, Scholberg K, Schoppmann S, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shah R, Shaikhiev A, Shaker F, Shaw D, Shiozawa M, Short S, Shustrov Y, Sinclair P, Smith B, Smy M, Sobczyk J, Sobel H, Sorel M, Southwell L, Stamoulis P, Steinmann J, Suda Y, Suzuki A, Suzuki K, Suzuki S, Suzuki Y, Tacik R, Tada M, Takahashi S, Takeda A, Takeuchi Y, Tanaka H, Tanaka H, Tanaka M, Terhorst D, Terri R, Thompson L, Thorley A, Tobayama S, Toki W, Tomura T, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Vacheret A, Vagins M, Vasseur G, Wachala T, Wakamatsu K, Walter C, Wark D, Warzycha W, Wascko M, Weber A, Wendell R, Wilkes R, Wilking M, Wilkinson C, Williamson Z, Wilson J, Wilson R, Wongjirad T, Yamada Y, Yamamoto K, Yanagisawa C, Yano T, Yen S, Yershov N, Yokoyama M, Yoo J, Yoshida K, Yuan T, Yu M, Zalewska A, Zalipska J, Zambelli L, Zaremba K, Ziembicki M, Zimmerman E, Zito M, Żmuda J. Measurement of the electron neutrino charged-current interaction rate on water with the T2K ND280π0detector. Int J Clin Exp Med 2015. [DOI: 10.1103/physrevd.91.112010] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
44
|
Abe K, Adam J, Aihara H, Andreopoulos C, Aoki S, Ariga A, Assylbekov S, Autiero D, Barbi M, Barker G, Barr G, Bartet-Friburg P, Bass M, Batkiewicz M, Bay F, Berardi V, Berger B, Berkman S, Bhadra S, Blaszczyk F, Blondel A, Bolognesi S, Bordoni S, Boyd S, Brailsford D, Bravar A, Bronner C, Buchanan N, Calland R, Caravaca Rodríguez J, Cartwright S, Castillo R, Catanesi M, Cervera A, Cherdack D, Chikuma N, Christodoulou G, Clifton A, Coleman J, Coleman S, Collazuol G, Connolly K, Cremonesi L, Dabrowska A, Danko I, Das R, Davis S, de Perio P, De Rosa G, Dealtry T, Dennis S, Densham C, Dewhurst D, Di Lodovico F, Di Luise S, Dolan S, Drapier O, Duffy K, Dumarchez J, Dytman S, Dziewiecki M, Emery-Schrenk S, Ereditato A, Escudero L, Ferchichi C, Feusels T, Finch A, Fiorentini G, Friend M, Fujii Y, Fukuda Y, Furmanski A, Galymov V, Garcia A, Giffin S, Giganti C, Gilje K, Goeldi D, Golan T, Gonin M, Grant N, Gudin D, Hadley D, Haegel L, Haesler A, Haigh M, Hamilton P, Hansen D, Hara T, Hartz M, Hasegawa T, Hastings N, Hayashino T, Hayato Y, Hearty C, Helmer R, Hierholzer M, Hignight J, Hillairet A, Himmel A, Hiraki T, Hirota S, Holeczek J, Horikawa S, Hosomi F, Huang K, Ichikawa A, Ieki K, Ieva M, Ikeda M, Imber J, Insler J, Irvine T, Ishida T, Ishii T, Iwai E, Iwamoto K, Iyogi K, Izmaylov A, Jacob A, Jamieson B, Jiang M, Johnson S, Jo J, Jonsson P, Jung C, Kabirnezhad M, Kaboth A, Kajita T, Kakuno H, Kameda J, Kanazawa Y, Karlen D, Karpikov I, Katori T, Kearns E, Khabibullin M, Khotjantsev A, Kielczewska D, Kikawa T, Kilinski A, Kim J, King S, Kisiel J, Kitching P, Kobayashi T, Koch L, Koga T, Kolaceke A, Konaka A, Kopylov A, Kormos L, Korzenev A, Koshio Y, Kropp W, Kubo H, Kudenko Y, Kurjata R, Kutter T, Lagoda J, Lamont I, Larkin E, Laveder M, Lawe M, Lazos M, Lindner T, Lister C, Litchfield R, Longhin A, Lopez J, Ludovici L, Magaletti L, Mahn K, Malek M, Manly S, Marino A, Marteau J, Martin J, Martins P, Martynenko S, Maruyama T, Matveev V, Mavrokoridis K, Mazzucato E, McCarthy M, McCauley N, McFarland K, McGrew C, Mefodiev A, Metelko C, Mezzetto M, Mijakowski P, Miller C, Minamino A, Mineev O, Missert A, Miura M, Moriyama S, Mueller T, Murakami A, Murdoch M, Murphy S, Myslik J, Nakadaira T, Nakahata M, Nakamura K, Nakamura K, Nakayama S, Nakaya T, Nakayoshi K, Nantais C, Nielsen C, Nirkko M, Nishikawa K, Nishimura Y, Nowak J, O’Keeffe H, Ohta R, Okumura K, Okusawa T, Oryszczak W, Oser S, Ovsyannikova T, Owen R, Oyama Y, Palladino V, Palomino J, Paolone V, Payne D, Perevozchikov O, Perkin J, Petrov Y, Pickard L, Pinzon Guerra E, Pistillo C, Plonski P, Poplawska E, Popov B, Posiadala-Zezula M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radicioni E, Ratoff P, Ravonel M, Rayner M, Redij A, Reeves M, Reinherz-Aronis E, Riccio C, Rodrigues P, Rojas P, Rondio E, Roth S, Rubbia A, Ruterbories D, Rychter A, Sacco R, Sakashita K, Sánchez F, Sato F, Scantamburlo E, Scholberg K, Schoppmann S, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shah R, Shaker F, Shaw D, Shiozawa M, Short S, Shustrov Y, Sinclair P, Smith B, Smy M, Sobczyk J, Sobel H, Sorel M, Southwell L, Stamoulis P, Steinmann J, Still B, Suda Y, Suzuki A, Suzuki K, Suzuki S, Suzuki Y, Tacik R, Tada M, Takahashi S, Takeda A, Takeuchi Y, Tanaka H, Tanaka H, Tanaka M, Terhorst D, Terri R, Thompson L, Thorley A, Tobayama S, Toki W, Tomura T, Totsuka Y, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Vacheret A, Vagins M, Vasseur G, Wachala T, Wakamatsu K, Walter C, Wark D, Warzycha W, Wascko M, Weber A, Wendell R, Wilkes R, Wilking M, Wilkinson C, Williamson Z, Wilson J, Wilson R, Wongjirad T, Yamada Y, Yamamoto K, Yanagisawa C, Yano T, Yen S, Yershov N, Yokoyama M, Yoo J, Yoshida K, Yuan T, Yu M, Zalewska A, Zalipska J, Zambelli L, Zaremba K, Ziembicki M, Zimmerman E, Zito M, Żmuda J. Measurement of theνμcharged current quasielastic cross section on carbon with the T2K on-axis neutrino beam. Int J Clin Exp Med 2015. [DOI: 10.1103/physrevd.91.112002] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
45
|
Jacob A, Delesalle D, Coopman S, Bridenne M, Guimber D, Turck D, Gottrand F, Michaud L. Safety of the One-Step Percutaneous Endoscopic Gastrostomy Button in Children. J Pediatr 2015; 166:1526-8. [PMID: 25868429 DOI: 10.1016/j.jpeds.2015.03.008] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/11/2014] [Revised: 02/09/2015] [Accepted: 03/04/2015] [Indexed: 12/28/2022]
Abstract
Pediatric experience using the single-stage percutaneous endoscopic gastrostomy button has been reported anecdotally. This 3-year prospective monocentric study, including 183 children, demonstrates that this technique is safe, with a low rate of infection, and compares favorably with the pull technique of percutaneous endoscopic gastrostomy while necessitating only one general anesthesia.
Collapse
Affiliation(s)
- Anne Jacob
- Division of Hepatology, Gastroenterology and Nutrition and Reference Centre for Congenital and Malformative Esophageal Disorders, Jeanne de Flandre Children's Hospital, Faculty of Medicine, University Lille2, Lille, France
| | - Dorothée Delesalle
- Division of Hepatology, Gastroenterology and Nutrition and Reference Centre for Congenital and Malformative Esophageal Disorders, Jeanne de Flandre Children's Hospital, Faculty of Medicine, University Lille2, Lille, France
| | - Stéphanie Coopman
- Division of Hepatology, Gastroenterology and Nutrition and Reference Centre for Congenital and Malformative Esophageal Disorders, Jeanne de Flandre Children's Hospital, Faculty of Medicine, University Lille2, Lille, France
| | - Marie Bridenne
- Division of Hepatology, Gastroenterology and Nutrition and Reference Centre for Congenital and Malformative Esophageal Disorders, Jeanne de Flandre Children's Hospital, Faculty of Medicine, University Lille2, Lille, France
| | - Dominique Guimber
- Division of Hepatology, Gastroenterology and Nutrition and Reference Centre for Congenital and Malformative Esophageal Disorders, Jeanne de Flandre Children's Hospital, Faculty of Medicine, University Lille2, Lille, France
| | - Dominique Turck
- Division of Hepatology, Gastroenterology and Nutrition and Reference Centre for Congenital and Malformative Esophageal Disorders, Jeanne de Flandre Children's Hospital, Faculty of Medicine, University Lille2, Lille, France
| | - Frédéric Gottrand
- Division of Hepatology, Gastroenterology and Nutrition and Reference Centre for Congenital and Malformative Esophageal Disorders, Jeanne de Flandre Children's Hospital, Faculty of Medicine, University Lille2, Lille, France
| | - Laurent Michaud
- Division of Hepatology, Gastroenterology and Nutrition and Reference Centre for Congenital and Malformative Esophageal Disorders, Jeanne de Flandre Children's Hospital, Faculty of Medicine, University Lille2, Lille, France.
| |
Collapse
|
46
|
Absoud M, Gadian J, Hellier J, Brex PA, Ciccarelli O, Giovannoni G, Kelly J, McCrone P, Murphy C, Palace J, Pickles A, Pike M, Robertson N, Jacob A, Lim M. Protocol for a multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin versus standard therapy for the treatment of transverse myelitis in adults and children (STRIVE). BMJ Open 2015; 5:e008312. [PMID: 26009577 PMCID: PMC4452744 DOI: 10.1136/bmjopen-2015-008312] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
INTRODUCTION Transverse myelitis (TM) is an immune-mediated disorder of the spinal cord which causes motor and sensory disturbance and limited recovery in 50% of patients. Standard treatment is steroids, and patients with more severe disease appear to respond to plasma exchange (PLEX). Intravenous immunoglobulin (IVIG) has also been used as an adjunct to steroids, but evidence is lacking. We propose the first randomised control trial in adults and children, to determine the benefit of additional treatment with IVIG. METHODS AND ANALYSIS 170 adults and children aged over 1 year with acute first episode TM or neuromyelitis optica (with myelitis) will be recruited over a 2.5-year period and followed up for 12 months. Participants randomised to the control arm will receive standard therapy of intravenous methylprednisolone (IVMP). The intervention arm will receive the above standard therapy, plus additional IVIG. Primary outcome will be a 2-point improvement on the American Spinal Injury Association (ASIA) Impairment scale at 6 months postrandomisation by blinded assessors. Additional secondary and tertiary outcome measures will be collected: ASIA motor and sensory scales, Kurtzke expanded disability status scale, International Spinal Cord Injury (SCI) Bladder/Bowel Data Set, Client Services Receipt Index, Pediatric Quality of Life Inventory, EQ-5D, SCI Pain and SCI Quality of Life Data Sets. Biological samples will be biobanked for future studies. After 6-months' follow-up of the first 52 recruited patients futility analysis will be carried out. Health economics analysis will be performed to calculate cost-effectiveness. After 6 months' recruitment futility analysis will be performed. ETHICS AND DISSEMINATION Research Ethics Committee Approval was obtained: 14/SC/1329. Current protocol: v3.0 (15/01/2015). Study findings will be published in peer-reviewed journals. TRIAL REGISTRATION NUMBERS This study is registered with EudraCT (REF: 2014-002335-34), Clinicaltrials.gov (REF: NCT02398994) and ISRCTN (REF: 12127581).
Collapse
Affiliation(s)
- M Absoud
- Department of Children's Neurosciences, Evelina Children's Hospital at Guy's and St Thomas' NHS Foundation Trust, King's Health Partners Academic Health Science Centre, London, UK
| | - J Gadian
- Department of Children's Neurosciences, Evelina Children's Hospital at Guy's and St Thomas' NHS Foundation Trust, King's Health Partners Academic Health Science Centre, London, UK
| | - J Hellier
- Department of Biostatistics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - P A Brex
- Department of Neurology, King's College Hospital NHS Foundation Trust, King's Health Partners Academic Health Science Centre, London, UK
| | - O Ciccarelli
- UCL Institute of Neurology, Queen Square, London, UK
| | - G Giovannoni
- Centre for Neuroscience and Trauma, Blizard Institute, University of London and Bart's Health NHS Trust, London, UK
| | - J Kelly
- King's Clinical Trials Unit, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - P McCrone
- Centre for the Economics of Mental and Physical Health, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - C Murphy
- King's Clinical Trials Unit, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - J Palace
- Department of Neurology, Oxford University Hospitals NHS Trust, Oxford, UK
| | - A Pickles
- Department of Biostatistics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - M Pike
- Department of Paediatric Neurology, Oxford University Hospitals NHS Trust, Oxford, UK
| | - N Robertson
- Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University and Cardiff and Vale NHS Trust, Cardiff, UK
| | - A Jacob
- The Walton Centre, Walton Centre NHS Foundation Trust, Liverpool, UK
| | - M Lim
- Department of Children's Neurosciences, Evelina Children's Hospital at Guy's and St Thomas' NHS Foundation Trust, King's Health Partners Academic Health Science Centre, London, UK
| |
Collapse
|
47
|
Abe K, Adam J, Aihara H, Akiri T, Andreopoulos C, Aoki S, Ariga A, Assylbekov S, Autiero D, Barbi M, Barker G, Barr G, Bartet-Friburg P, Bass M, Batkiewicz M, Bay F, Berardi V, Berger B, Berkman S, Bhadra S, Blaszczyk F, Blondel A, Bojechko C, Bolognesi S, Bordoni S, Boyd S, Brailsford D, Bravar A, Bronner C, Buchanan N, Calland R, Caravaca Rodríguez J, Cartwright S, Castillo R, Catanesi M, Cervera A, Cherdack D, Christodoulou G, Clifton A, Coleman J, Coleman S, Collazuol G, Connolly K, Cremonesi L, Dabrowska A, Das R, Davis S, de Perio P, De Rosa G, Dealtry T, Dennis S, Densham C, Dewhurst D, Di Lodovico F, Di Luise S, Dolan S, Drapier O, Duboyski T, Duffy K, Dumarchez J, Dytman S, Dziewiecki M, Emery-Schrenk S, Ereditato A, Escudero L, Feusels T, Finch A, Fiorentini G, Friend M, Fujii Y, Fukuda Y, Furmanski A, Galymov V, Garcia A, Giffin S, Giganti C, Gilje K, Goeldi D, Golan T, Gonin M, Grant N, Gudin D, Hadley D, Haegel L, Haesler A, Haigh M, Hamilton P, Hansen D, Hara T, Hartz M, Hasegawa T, Hastings N, Hayashino T, Hayato Y, Hearty C, Helmer R, Hierholzer M, Hignight J, Hillairet A, Himmel A, Hiraki T, Hirota S, Holeczek J, Horikawa S, Huang K, Ichikawa A, Ieki K, Ieva M, Ikeda M, Imber J, Insler J, Irvine T, Ishida T, Ishii T, Iwai E, Iwamoto K, Iyogi K, Izmaylov A, Jacob A, Jamieson B, Jiang M, Johnson S, Jo J, Jonsson P, Jung C, Kabirnezhad M, Kaboth A, Kajita T, Kakuno H, Kameda J, Kanazawa Y, Karlen D, Karpikov I, Katori T, Kearns E, Khabibullin M, Khotjantsev A, Kielczewska D, Kikawa T, Kilinski A, Kim J, King S, Kisiel J, Kitching P, Kobayashi T, Koch L, Koga T, Kolaceke A, Konaka A, Kormos L, Korzenev A, Koshio Y, Kropp W, Kubo H, Kudenko Y, Kurjata R, Kutter T, Lagoda J, Lamont I, Larkin E, Laveder M, Lawe M, Lazos M, Lindner T, Lister C, Litchfield R, Longhin A, Lopez J, Ludovici L, Magaletti L, Mahn K, Malek M, Manly S, Marino A, Marteau J, Martin J, Martins P, Martynenko S, Maruyama T, Matveev V, Mavrokoridis K, Mazzucato E, McCarthy M, McCauley N, McFarland K, McGrew C, Mefodiev A, Metelko C, Mezzetto M, Mijakowski P, Miller C, Minamino A, Mineev O, Missert A, Miura M, Moriyama S, Mueller T, Murakami A, Murdoch M, Murphy S, Myslik J, Nakadaira T, Nakahata M, Nakamura K, Nakamura K, Nakayama S, Nakaya T, Nakayoshi K, Nantais C, Nielsen C, Nirkko M, Nishikawa K, Nishimura Y, Nowak J, O’Keeffe H, Ohta R, Okumura K, Okusawa T, Oryszczak W, Oser S, Ovsyannikova T, Owen R, Oyama Y, Palladino V, Palomino J, Paolone V, Payne D, Perevozchikov O, Perkin J, Petrov Y, Pickard L, Pinzon Guerra E, Pistillo C, Plonski P, Poplawska E, Popov B, Posiadala-Zezula M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radicioni E, Ratoff P, Ravonel M, Rayner M, Redij A, Reeves M, Reinherz-Aronis E, Riccio C, Rodrigues P, Rojas P, Rondio E, Roth S, Rubbia A, Ruterbories D, Rychter A, Sacco R, Sakashita K, Sánchez F, Sato F, Scantamburlo E, Scholberg K, Schoppmann S, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shah R, Shaker F, Shaw D, Shiozawa M, Short S, Shustrov Y, Sinclair P, Smith B, Smy M, Sobczyk J, Sobel H, Sorel M, Southwell L, Stamoulis P, Steinmann J, Still B, Suda Y, Suzuki A, Suzuki K, Suzuki S, Suzuki Y, Tacik R, Tada M, Takahashi S, Takeda A, Takeuchi Y, Tanaka H, Tanaka H, Tanaka M, Terhorst D, Terri R, Thompson L, Thorley A, Tobayama S, Toki W, Tomura T, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Vacheret A, Vagins M, Vasseur G, Wachala T, Wakamatsu K, Wallbank M, Walter C, Wark D, Warzycha W, Wascko M, Weber A, Wendell R, Wilkes R, Wilking M, Wilkinson C, Williamson Z, Wilson J, Wilson R, Wongjirad T, Yamada Y, Yamamoto K, Yanagisawa C, Yano T, Yen S, Yershov N, Yokoyama M, Yoshida K, Yuan T, Yu M, Zalewska A, Zalipska J, Zambelli L, Zaremba K, Ziembicki M, Zimmerman E, Zito M, Żmuda J. Search for short baselineνedisappearance with the T2K near detector. Int J Clin Exp Med 2015. [DOI: 10.1103/physrevd.91.051102] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
48
|
Warren DT, Tajsic T, Porter LJ, Minaisah RM, Cobb A, Jacob A, Rajgor D, Zhang QP, Shanahan CM. Nesprin-2-dependent ERK1/2 compartmentalisation regulates the DNA damage response in vascular smooth muscle cell ageing. Cell Death Differ 2015; 22:1540-50. [PMID: 25744025 PMCID: PMC4532777 DOI: 10.1038/cdd.2015.12] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2014] [Revised: 12/19/2014] [Accepted: 01/21/2015] [Indexed: 11/30/2022] Open
Abstract
Prelamin A accumulation and persistent DNA damage response (DDR) are hallmarks of vascular smooth muscle cell (VSMC) ageing and dysfunction. Although prelamin A is proposed to interfere with DNA repair, our understanding of the crosstalk between prelamin A and the repair process remains limited. The extracellular signal-regulated kinases 1 and 2 (ERK1/2) have emerged as key players in the DDR and are known to enhance ataxia telangiectasia-mutated protein (ATM) activity at DNA lesions, and in this study, we identified a novel relationship between prelamin A accumulation and ERK1/2 nuclear compartmentalisation during VSMC ageing. We show both prelamin A accumulation and increased DNA damage occur concomitantly, before VSMC replicative senescence, and induce the localisation of ERK1/2 to promyelocytic leukaemia protein nuclear bodies (PML NBs) at the sites of DNA damage via nesprin-2 and lamin A interactions. Importantly, VSMCs treated with DNA damaging agents also displayed prelamin A accumulation and ERK compartmentalisation at PML NBs, suggesting that prelamin A and nesprin-2 are novel components of the DDR. In support of this, disruption of ERK compartmentalisation at PML NBs, by either depletion of nesprin-2 or lamins A/C, resulted in the loss of ATM from DNA lesions. However, ATM signalling and DNA repair remained intact after lamins A/C depletion, whereas nesprin-2 disruption ablated downstream Chk2 activation and induced genomic instability. We conclude that lamins A/C and PML act as scaffolds to organise DNA-repair foci and compartmentalise nesprin-2/ERK signalling. However, nesprin-2/ERK signalling fidelity, but not their compartmentalisation at PML NBs, is essential for efficient DDR in VSMCs.
Collapse
Affiliation(s)
- D T Warren
- British Heart Foundation Centre of Research Excellence, Cardiovascular Division, King's College London, London SE5 9NU, UK
| | - T Tajsic
- Department of Medicine, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK
| | - L J Porter
- British Heart Foundation Centre of Research Excellence, Cardiovascular Division, King's College London, London SE5 9NU, UK
| | - R M Minaisah
- British Heart Foundation Centre of Research Excellence, Cardiovascular Division, King's College London, London SE5 9NU, UK
| | - A Cobb
- British Heart Foundation Centre of Research Excellence, Cardiovascular Division, King's College London, London SE5 9NU, UK
| | - A Jacob
- British Heart Foundation Centre of Research Excellence, Cardiovascular Division, King's College London, London SE5 9NU, UK
| | - D Rajgor
- British Heart Foundation Centre of Research Excellence, Cardiovascular Division, King's College London, London SE5 9NU, UK
| | - Q P Zhang
- British Heart Foundation Centre of Research Excellence, Cardiovascular Division, King's College London, London SE5 9NU, UK
| | - C M Shanahan
- British Heart Foundation Centre of Research Excellence, Cardiovascular Division, King's College London, London SE5 9NU, UK
| |
Collapse
|
49
|
Fasching PA, Fehm T, Kellner S, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Würstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Fersis N, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesslet T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauß T, Thomssen C, Kümmel S, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Jacob A, Schmidt K, Belleville E, Hadji P, Wallwiener D, Grischke EM, Beckmann MW, Brucker SY. Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study. Geburtshilfe Frauenheilkd 2014; 74:1137-1143. [PMID: 25568468 DOI: 10.1055/s-0034-1383401] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2014] [Revised: 11/17/2014] [Accepted: 11/18/2014] [Indexed: 10/24/2022] Open
Abstract
Introduction: The EvaluateTM study (Evaluation of therapy management and patient compliance in postmenopausal hormone receptor-positive breast cancer patients receiving letrozole treatment) is a prospective, non-interventional study for the assessment of therapy management and compliance in the routine care of postmenopausal women with invasive hormone receptor-positive breast cancer receiving letrozole. The parameters for inclusion in the study are presented and discussed here. Material and Methods: Between January 2008 and December 2009 a total of 5045 patients in 310 study centers were recruited to the EvaluateTM study. Inclusion criteria were hormone receptor-positive breast cancer and adjuvant treatment or metastasis. 373 patients were excluded from the analysis for various reasons. Results: A total of 4420 patients receiving adjuvant treatment and 252 patients with metastasis receiving palliative treatment were included in the study. For 4181 patients receiving adjuvant treatment, treatment with the aromatase inhibitor letrozole commenced immediately after surgery (upfront). Two hundred patients had initially received tamoxifen and started aromatase inhibitor treatment with letrozole at 1-5 years after diagnosis (switch), und 39 patients only commenced letrozole treatment 5-10 years after diagnosis (extended endocrine therapy). Patient and tumor characteristics were within expected ranges, as were comorbidities and concurrent medication. Conclusion: The data from the EvaluateTM study will offer a good overview of therapy management in the routine care of postmenopausal women with hormone receptor-positive breast cancer. Planned analyses will look at therapy compliance and patient satisfaction with how information is conveyed and the contents of the conveyed information.
Collapse
Affiliation(s)
- P A Fasching
- Universitäts-Brustzentrum Franken, Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen
| | - T Fehm
- Universitäts-Frauenklinik Düsseldorf, Düsseldorf ; Universitätsfrauenklinik Tübingen, Tübingen
| | - S Kellner
- Universitäts-Brustzentrum Franken, Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen
| | - J de Waal
- Frauenklinik im Klinikum Dachau, Dachau
| | - M Rezai
- Luisenkrankenhaus Düsseldorf, Düsseldorf
| | - B Baier
- Frauenklinik im Klinikum Dachau, Dachau
| | - G Baake
- Klinikum Pinneberg, Pinneberg
| | | | | | - M Warm
- Brustzentrum, Universitäts-Frauenklinik Köln, Köln ; Brustzentrum, Klinken der Stadt Köln gGmbH Holweide, Köln
| | - N Harbeck
- Brustzentrum, Universitäts-Frauenklinik Köln, Köln ; Brustzentrum der Universität München, Frauenkliniken Großhadern und Maistrasse-Innenstadt, München
| | - R Würstlein
- Brustzentrum, Universitäts-Frauenklinik Köln, Köln ; Brustzentrum der Universität München, Frauenkliniken Großhadern und Maistrasse-Innenstadt, München
| | - J-U Deuker
- Vinzenzkrankenhaus Hannover gGmbH, Hannover
| | - P Dall
- Frauenklinik, Klinikum Lüneburg, Lüneburg
| | - B Richter
- Elblandkliniken Meißen-Radebeul Standort Radebeul, Radebeul
| | | | - C Brucker
- Universitätsklinik für Frauenheilkunde, Paracelsus Medizinische Privatuniversität, Nürnberg
| | - J W Siebers
- Frauenklinik des St. Josefsklinik Offenburg, Offenburg
| | - N Fersis
- Frauenklinik, Klinikum Bayreuth GmbH, Comprehensive Cancer Center Erlangen-EMN, Bayreuth
| | - T Kuhn
- Karl-Olga-Krankenhaus, Stuttgart
| | - C Wolf
- Medizinisches Zentrum Ulm, Ulm
| | | | - G-P Breitbach
- Städtisches Klinikum Neunkirchen Gynäkologie und Geburtshilfe, Neunkirchen
| | - W Janni
- Frauenklinik des Universitätsklinikums Ulm, Ulm
| | - R Landthaler
- Gynäkologische Praxis in der Kreisklinik, Krumbach
| | - A Kohls
- Evangelisches Krankenhaus Ludwigsfelde-Teltow, Ludwigsfelde
| | - D Rezek
- Marien-Hospital Wesel, Wesel
| | - T Noesslet
- Frauenklinik am Kreiskrankenhaus Hameln, Hameln
| | - G Fischer
- Landkreis Mittweida Krankenhaus gGmbH, Mittweida
| | - S Henschen
- Johanniter Krankenhaus Genthin Stendal gGmbH, Stendal
| | - T Praetz
- Praxis Dr. Praetz, Bad Mergentheim
| | - V Heyl
- Asklepios Paulinen Klinik Wiesbaden, Wiesbaden
| | - T Kühn
- Frauenklinik, Städtische Kliniken Esslingen a. N., Esslingen
| | | | - C Thomssen
- Frauenklinik, Universitätsklinik Halle Wittenberg, Halle
| | - S Kümmel
- Brustzentrum, Kliniken Essen Mitte, Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen
| | - A Hohn
- Kreiskrankenhaus Rendsburg, Rendsburg
| | - H Tesch
- Onkologie Bethanien, Frankfurt
| | - C Mundhenke
- Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel
| | - A Hein
- Universitäts-Brustzentrum Franken, Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen
| | - C Rauh
- Universitäts-Brustzentrum Franken, Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen
| | - C M Bayer
- Universitäts-Brustzentrum Franken, Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen
| | - A Jacob
- Novartis Pharma GmbH, Nürnberg
| | | | | | - P Hadji
- Krankenhaus Nordwest, Klinik für Gynäkologie und Gebursthilfe, Frankfurt
| | | | | | - M W Beckmann
- Universitäts-Brustzentrum Franken, Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen
| | | |
Collapse
|
50
|
Abe K, Adam J, Aihara H, Akiri T, Andreopoulos C, Aoki S, Ariga A, Assylbekov S, Autiero D, Barbi M, Barker GJ, Barr G, Bass M, Batkiewicz M, Bay F, Berardi V, Berger BE, Berkman S, Bhadra S, Blaszczyk FDM, Blondel A, Bojechko C, Bordoni S, Boyd SB, Brailsford D, Bravar A, Bronner C, Buchanan N, Calland RG, Caravaca Rodríguez J, Cartwright SL, Castillo R, Catanesi MG, Cervera A, Cherdack D, Christodoulou G, Clifton A, Coleman J, Coleman SJ, Collazuol G, Connolly K, Cremonesi L, Dabrowska A, Danko I, Das R, Davis S, de Perio P, De Rosa G, Dealtry T, Dennis SR, Densham C, Dewhurst D, Di Lodovico F, Di Luise S, Drapier O, Duboyski T, Duffy K, Dumarchez J, Dytman S, Dziewiecki M, Emery-Schrenk S, Ereditato A, Escudero L, Finch AJ, Friend M, Fujii Y, Fukuda Y, Furmanski AP, Galymov V, Giffin S, Giganti C, Gilje K, Goeldi D, Golan T, Gonin M, Grant N, Gudin D, Hadley DR, Haesler A, Haigh MD, Hamilton P, Hansen D, Hara T, Hartz M, Hasegawa T, Hastings NC, Hayato Y, Hearty C, Helmer RL, Hierholzer M, Hignight J, Hillairet A, Himmel A, Hiraki T, Hirota S, Holeczek J, Horikawa S, Huang K, Ichikawa AK, Ieki K, Ieva M, Ikeda M, Imber J, Insler J, Irvine TJ, Ishida T, Ishii T, Iwai E, Iwamoto K, Iyogi K, Izmaylov A, Jacob A, Jamieson B, Johnson RA, Jo JH, Jonsson P, Jung CK, Kabirnezhad M, Kaboth AC, Kajita T, Kakuno H, Kameda J, Kanazawa Y, Karlen D, Karpikov I, Katori T, Kearns E, Khabibullin M, Khotjantsev A, Kielczewska D, Kikawa T, Kilinski A, Kim J, Kisiel J, Kitching P, Kobayashi T, Koch L, Kolaceke A, Konaka A, Kormos LL, Korzenev A, Koshio Y, Kropp W, Kubo H, Kudenko Y, Kurjata R, Kutter T, Lagoda J, Lamont I, Larkin E, Laveder M, Lawe M, Lazos M, Lindner T, Lister C, Litchfield RP, Longhin A, Ludovici L, Magaletti L, Mahn K, Malek M, Manly S, Marino AD, Marteau J, Martin JF, Martynenko S, Maruyama T, Matveev V, Mavrokoridis K, Mazzucato E, McCarthy M, McCauley N, McFarland KS, McGrew C, Metelko C, Mijakowski P, Miller CA, Minamino A, Mineev O, Missert A, Miura M, Moriyama S, Mueller TA, Murakami A, Murdoch M, Murphy S, Myslik J, Nakadaira T, Nakahata M, Nakamura K, Nakayama S, Nakaya T, Nakayoshi K, Nielsen C, Nirkko M, Nishikawa K, Nishimura Y, O'Keeffe HM, Ohta R, Okumura K, Okusawa T, Oryszczak W, Oser SM, Owen RA, Oyama Y, Palladino V, Palomino JL, Paolone V, Payne D, Perevozchikov O, Perkin JD, Petrov Y, Pickard L, Pinzon Guerra ES, Pistillo C, Plonski P, Poplawska E, Popov B, Posiadala M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radicioni E, Ratoff PN, Ravonel M, Rayner MAM, Redij A, Reeves M, Reinherz-Aronis E, Rodrigues PA, Rojas P, Rondio E, Roth S, Rubbia A, Ruterbories D, Sacco R, Sakashita K, Sánchez F, Sato F, Scantamburlo E, Scholberg K, Schoppmann S, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shiozawa M, Short S, Shustrov Y, Sinclair P, Smith B, Smy M, Sobczyk JT, Sobel H, Sorel M, Southwell L, Stamoulis P, Steinmann J, Still B, Suda Y, Suzuki A, Suzuki K, Suzuki SY, Suzuki Y, Tacik R, Tada M, Takahashi S, Takeda A, Takeuchi Y, Tanaka HK, Tanaka HA, Tanaka MM, Terhorst D, Terri R, Thompson LF, Thorley A, Tobayama S, Toki W, Tomura T, Totsuka Y, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Vacheret A, Vagins M, Vasseur G, Wachala T, Waldron AV, Walter CW, Wark D, Wascko MO, Weber A, Wendell R, Wilkes RJ, Wilking MJ, Wilkinson C, Williamson Z, Wilson JR, Wilson RJ, Wongjirad T, Yamada Y, Yamamoto K, Yanagisawa C, Yano T, Yen S, Yershov N, Yokoyama M, Yuan T, Yu M, Zalewska A, Zalipska J, Zambelli L, Zaremba K, Ziembicki M, Zimmerman ED, Zito M, Żmuda J. Measurement of the inclusive electron neutrino charged current cross section on carbon with the T2K near detector. Phys Rev Lett 2014; 113:241803. [PMID: 25541766 DOI: 10.1103/physrevlett.113.241803] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/28/2014] [Indexed: 06/04/2023]
Abstract
The T2K off-axis near detector ND280 is used to make the first differential cross-section measurements of electron neutrino charged current interactions at energies ∼1 GeV as a function of electron momentum, electron scattering angle, and four-momentum transfer of the interaction. The total flux-averaged ν(e) charged current cross section on carbon is measured to be ⟨σ⟩(ϕ)=1.11±0.10(stat)±0.18(syst)×10⁻³⁸ cm²/nucleon. The differential and total cross-section measurements agree with the predictions of two leading neutrino interaction generators, NEUT and GENIE. The NEUT prediction is 1.23×10⁻³⁸ cm²/nucleon and the GENIE prediction is 1.08×10⁻³⁸ cm²/nucleon. The total ν(e) charged current cross-section result is also in agreement with data from the Gargamelle experiment.
Collapse
Affiliation(s)
- K Abe
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - J Adam
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - H Aihara
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), Todai Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan and Department of Physics, University of Tokyo, Tokyo, Japan
| | - T Akiri
- Department of Physics, Duke University, Durham, North Carolina, USA
| | - C Andreopoulos
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - S Aoki
- Kobe University, Kobe, Japan
| | - A Ariga
- Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, Bern, Switzerland
| | - S Assylbekov
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - D Autiero
- Université de Lyon, Université Claude Bernard Lyon 1, IPN Lyon (IN2P3), Villeurbanne, France
| | - M Barbi
- Department of Physics, University of Regina, Regina, Saskatchewan, Canada
| | - G J Barker
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - G Barr
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - M Bass
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - M Batkiewicz
- H. Niewodniczanski Institute of Nuclear Physics PAN, Cracow, Poland
| | - F Bay
- Institute for Particle Physics, ETH Zurich, Zurich, Switzerland
| | - V Berardi
- Dipartimento Interuniversitario di Fisica, INFN Sezione di Bari and Università e Politecnico di Bari, Bari, Italy
| | - B E Berger
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA and Kavli Institute for the Physics and Mathematics of the Universe (WPI), Todai Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - S Berkman
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - S Bhadra
- Department of Physics and Astronomy, York University, Toronto, Ontario, Canada
| | - F d M Blaszczyk
- Department of Physics and Astronomy, Louisiana State University, Baton Rouge, Louisiana, USA
| | - A Blondel
- Section de Physique, University of Geneva, DPNC, Geneva, Switzerland
| | - C Bojechko
- Department of Physics and Astronomy, University of Victoria, Victoria, British Columbia, Canada
| | - S Bordoni
- Institut de Fisica d'Altes Energies (IFAE), Bellaterra (Barcelona), Spain
| | - S B Boyd
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - D Brailsford
- Department of Physics, Imperial College London, London, United Kingdom
| | - A Bravar
- Section de Physique, University of Geneva, DPNC, Geneva, Switzerland
| | - C Bronner
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), Todai Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - N Buchanan
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - R G Calland
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | | | - S L Cartwright
- Department of Physics and Astronomy, University of Sheffield, Sheffield, United Kingdom
| | - R Castillo
- Institut de Fisica d'Altes Energies (IFAE), Bellaterra (Barcelona), Spain
| | - M G Catanesi
- Dipartimento Interuniversitario di Fisica, INFN Sezione di Bari and Università e Politecnico di Bari, Bari, Italy
| | - A Cervera
- IFIC (CSIC & University of Valencia), Valencia, Spain
| | - D Cherdack
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - G Christodoulou
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - A Clifton
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - J Coleman
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - S J Coleman
- Department of Physics, University of Colorado at Boulder, Boulder, Colorado, USA
| | - G Collazuol
- Dipartimento di Fisica, INFN Sezione di Padova and Università di Padova, Padova, Italy
| | - K Connolly
- Department of Physics, University of Washington, Seattle, Washington, USA
| | - L Cremonesi
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - A Dabrowska
- H. Niewodniczanski Institute of Nuclear Physics PAN, Cracow, Poland
| | - I Danko
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - R Das
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - S Davis
- Department of Physics, University of Washington, Seattle, Washington, USA
| | - P de Perio
- Department of Physics, University of Toronto, Toronto, Ontario, Canada
| | - G De Rosa
- Dipartimento di Fisica, INFN Sezione di Napoli and Università di Napoli, Napoli, Italy
| | - T Dealtry
- Department of Physics, Oxford University, Oxford, United Kingdom and STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - S R Dennis
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom and Department of Physics, University of Warwick, Coventry, United Kingdom
| | - C Densham
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - D Dewhurst
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - F Di Lodovico
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - S Di Luise
- Institute for Particle Physics, ETH Zurich, Zurich, Switzerland
| | - O Drapier
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, IN2P3-CNRS, Palaiseau, France
| | - T Duboyski
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - K Duffy
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - J Dumarchez
- Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), UPMC, Université Paris Diderot, CNRS/IN2P3, Paris, France
| | - S Dytman
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - M Dziewiecki
- Institute of Radioelectronics, Warsaw University of Technology, Warsaw, Poland
| | | | - A Ereditato
- Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, Bern, Switzerland
| | - L Escudero
- IFIC (CSIC & University of Valencia), Valencia, Spain
| | - A J Finch
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - M Friend
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - Y Fujii
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - Y Fukuda
- Department of Physics, Miyagi University of Education, Sendai, Japan
| | - A P Furmanski
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - V Galymov
- Université de Lyon, Université Claude Bernard Lyon 1, IPN Lyon (IN2P3), Villeurbanne, France
| | - S Giffin
- Department of Physics, University of Regina, Regina, Saskatchewan, Canada
| | - C Giganti
- Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), UPMC, Université Paris Diderot, CNRS/IN2P3, Paris, France
| | - K Gilje
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - D Goeldi
- Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, Bern, Switzerland
| | - T Golan
- Faculty of Physics and Astronomy, Wroclaw University, Wroclaw, Poland
| | - M Gonin
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, IN2P3-CNRS, Palaiseau, France
| | - N Grant
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - D Gudin
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - D R Hadley
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - A Haesler
- Section de Physique, University of Geneva, DPNC, Geneva, Switzerland
| | - M D Haigh
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - P Hamilton
- Department of Physics, Imperial College London, London, United Kingdom
| | - D Hansen
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - T Hara
- Kobe University, Kobe, Japan
| | - M Hartz
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), Todai Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan and TRIUMF, Vancouver, British Columbia, Canada
| | - T Hasegawa
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - N C Hastings
- Department of Physics, University of Regina, Regina, Saskatchewan, Canada
| | - Y Hayato
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), Todai Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan and Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - C Hearty
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - R L Helmer
- TRIUMF, Vancouver, British Columbia, Canada
| | - M Hierholzer
- Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, Bern, Switzerland
| | - J Hignight
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - A Hillairet
- Department of Physics and Astronomy, University of Victoria, Victoria, British Columbia, Canada
| | - A Himmel
- Department of Physics, Duke University, Durham, North Carolina, USA
| | - T Hiraki
- Department of Physics, Kyoto University, Kyoto, Japan
| | - S Hirota
- Department of Physics, Kyoto University, Kyoto, Japan
| | - J Holeczek
- Institute of Physics, University of Silesia, Katowice, Poland
| | - S Horikawa
- Institute for Particle Physics, ETH Zurich, Zurich, Switzerland
| | - K Huang
- Department of Physics, Kyoto University, Kyoto, Japan
| | - A K Ichikawa
- Department of Physics, Kyoto University, Kyoto, Japan
| | - K Ieki
- Department of Physics, Kyoto University, Kyoto, Japan
| | - M Ieva
- Institut de Fisica d'Altes Energies (IFAE), Bellaterra (Barcelona), Spain
| | - M Ikeda
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - J Imber
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - J Insler
- Department of Physics and Astronomy, Louisiana State University, Baton Rouge, Louisiana, USA
| | - T J Irvine
- Institute for Cosmic Ray Research, University of Tokyo, Research Center for Cosmic Neutrinos, Kashiwa, Japan
| | - T Ishida
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - T Ishii
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - E Iwai
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - K Iwamoto
- Department of Physics and Astronomy, University of Rochester, Rochester, New York, USA
| | - K Iyogi
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - A Izmaylov
- IFIC (CSIC & University of Valencia), Valencia, Spain and Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - A Jacob
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - B Jamieson
- Department of Physics, University of Winnipeg, Winnipeg, Manitoba, Canada
| | - R A Johnson
- Department of Physics, University of Colorado at Boulder, Boulder, Colorado, USA
| | - J H Jo
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - P Jonsson
- Department of Physics, Imperial College London, London, United Kingdom
| | - C K Jung
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - M Kabirnezhad
- National Centre for Nuclear Research, Warsaw, Poland
| | - A C Kaboth
- Department of Physics, Imperial College London, London, United Kingdom
| | - T Kajita
- Institute for Cosmic Ray Research, University of Tokyo, Research Center for Cosmic Neutrinos, Kashiwa, Japan
| | - H Kakuno
- Department of Physics, Tokyo Metropolitan University, Tokyo, Japan
| | - J Kameda
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - Y Kanazawa
- Department of Physics, University of Tokyo, Tokyo, Japan
| | - D Karlen
- TRIUMF, Vancouver, British Columbia, Canada and Department of Physics and Astronomy, University of Victoria, Victoria, British Columbia, Canada
| | - I Karpikov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - T Katori
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - E Kearns
- Department of Physics, Boston University, Boston, Massachusetts, USA and Kavli Institute for the Physics and Mathematics of the Universe (WPI), Todai Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - M Khabibullin
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - A Khotjantsev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - D Kielczewska
- Faculty of Physics, University of Warsaw, Warsaw, Poland
| | - T Kikawa
- Department of Physics, Kyoto University, Kyoto, Japan
| | - A Kilinski
- National Centre for Nuclear Research, Warsaw, Poland
| | - J Kim
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - J Kisiel
- Institute of Physics, University of Silesia, Katowice, Poland
| | - P Kitching
- Department of Physics, University of Alberta, Centre for Particle Physics, Edmonton, Alberta, Canada
| | - T Kobayashi
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - L Koch
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - A Kolaceke
- Department of Physics, University of Regina, Regina, Saskatchewan, Canada
| | - A Konaka
- TRIUMF, Vancouver, British Columbia, Canada
| | - L L Kormos
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - A Korzenev
- Section de Physique, University of Geneva, DPNC, Geneva, Switzerland
| | - Y Koshio
- Department of Physics, Okayama University, Okayama, Japan
| | - W Kropp
- Department of Physics and Astronomy, University of California, Irvine, Irvine, California, USA
| | - H Kubo
- Department of Physics, Kyoto University, Kyoto, Japan
| | - Y Kudenko
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - R Kurjata
- Institute of Radioelectronics, Warsaw University of Technology, Warsaw, Poland
| | - T Kutter
- Department of Physics and Astronomy, Louisiana State University, Baton Rouge, Louisiana, USA
| | - J Lagoda
- National Centre for Nuclear Research, Warsaw, Poland
| | - I Lamont
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - E Larkin
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - M Laveder
- Dipartimento di Fisica, INFN Sezione di Padova and Università di Padova, Padova, Italy
| | - M Lawe
- Department of Physics and Astronomy, University of Sheffield, Sheffield, United Kingdom
| | - M Lazos
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - T Lindner
- TRIUMF, Vancouver, British Columbia, Canada
| | - C Lister
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - R P Litchfield
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - A Longhin
- Dipartimento di Fisica, INFN Sezione di Padova and Università di Padova, Padova, Italy
| | - L Ludovici
- INFN Sezione di Roma and Università di Roma "La Sapienza", Roma, Italy
| | - L Magaletti
- Dipartimento Interuniversitario di Fisica, INFN Sezione di Bari and Università e Politecnico di Bari, Bari, Italy
| | - K Mahn
- TRIUMF, Vancouver, British Columbia, Canada
| | - M Malek
- Department of Physics, Imperial College London, London, United Kingdom
| | - S Manly
- Department of Physics and Astronomy, University of Rochester, Rochester, New York, USA
| | - A D Marino
- Department of Physics, University of Colorado at Boulder, Boulder, Colorado, USA
| | - J Marteau
- Université de Lyon, Université Claude Bernard Lyon 1, IPN Lyon (IN2P3), Villeurbanne, France
| | - J F Martin
- Department of Physics, University of Toronto, Toronto, Ontario, Canada
| | - S Martynenko
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - T Maruyama
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - V Matveev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - K Mavrokoridis
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | | | - M McCarthy
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - N McCauley
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - K S McFarland
- Department of Physics and Astronomy, University of Rochester, Rochester, New York, USA
| | - C McGrew
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - C Metelko
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - P Mijakowski
- National Centre for Nuclear Research, Warsaw, Poland
| | - C A Miller
- TRIUMF, Vancouver, British Columbia, Canada
| | - A Minamino
- Department of Physics, Kyoto University, Kyoto, Japan
| | - O Mineev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - A Missert
- Department of Physics, University of Colorado at Boulder, Boulder, Colorado, USA
| | - M Miura
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - S Moriyama
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - Th A Mueller
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, IN2P3-CNRS, Palaiseau, France
| | - A Murakami
- Department of Physics, Kyoto University, Kyoto, Japan
| | - M Murdoch
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - S Murphy
- Institute for Particle Physics, ETH Zurich, Zurich, Switzerland
| | - J Myslik
- Department of Physics and Astronomy, University of Victoria, Victoria, British Columbia, Canada
| | - T Nakadaira
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - M Nakahata
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), Todai Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan and Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - K Nakamura
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan and Kavli Institute for the Physics and Mathematics of the Universe (WPI), Todai Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - S Nakayama
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - T Nakaya
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), Todai Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan and Department of Physics, Kyoto University, Kyoto, Japan
| | - K Nakayoshi
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - C Nielsen
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - M Nirkko
- Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, Bern, Switzerland
| | - K Nishikawa
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - Y Nishimura
- Institute for Cosmic Ray Research, University of Tokyo, Research Center for Cosmic Neutrinos, Kashiwa, Japan
| | - H M O'Keeffe
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - R Ohta
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - K Okumura
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), Todai Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan and Institute for Cosmic Ray Research, University of Tokyo, Research Center for Cosmic Neutrinos, Kashiwa, Japan
| | - T Okusawa
- Department of Physics, Osaka City University, Osaka, Japan
| | - W Oryszczak
- Faculty of Physics, University of Warsaw, Warsaw, Poland
| | - S M Oser
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - R A Owen
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - Y Oyama
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - V Palladino
- Dipartimento di Fisica, INFN Sezione di Napoli and Università di Napoli, Napoli, Italy
| | - J L Palomino
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - V Paolone
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - D Payne
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - O Perevozchikov
- Department of Physics and Astronomy, Louisiana State University, Baton Rouge, Louisiana, USA
| | - J D Perkin
- Department of Physics and Astronomy, University of Sheffield, Sheffield, United Kingdom
| | - Y Petrov
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - L Pickard
- Department of Physics and Astronomy, University of Sheffield, Sheffield, United Kingdom
| | - E S Pinzon Guerra
- Department of Physics and Astronomy, York University, Toronto, Ontario, Canada
| | - C Pistillo
- Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, Bern, Switzerland
| | - P Plonski
- Institute of Radioelectronics, Warsaw University of Technology, Warsaw, Poland
| | - E Poplawska
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - B Popov
- Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), UPMC, Université Paris Diderot, CNRS/IN2P3, Paris, France
| | - M Posiadala
- Faculty of Physics, University of Warsaw, Warsaw, Poland
| | | | | | - P Przewlocki
- National Centre for Nuclear Research, Warsaw, Poland
| | - B Quilain
- Laboratoire Leprince-Ringuet, Ecole Polytechnique, IN2P3-CNRS, Palaiseau, France
| | - E Radicioni
- Dipartimento Interuniversitario di Fisica, INFN Sezione di Bari and Università e Politecnico di Bari, Bari, Italy
| | - P N Ratoff
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - M Ravonel
- Section de Physique, University of Geneva, DPNC, Geneva, Switzerland
| | - M A M Rayner
- Section de Physique, University of Geneva, DPNC, Geneva, Switzerland
| | - A Redij
- Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, Bern, Switzerland
| | - M Reeves
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - E Reinherz-Aronis
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - P A Rodrigues
- Department of Physics and Astronomy, University of Rochester, Rochester, New York, USA
| | - P Rojas
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - E Rondio
- National Centre for Nuclear Research, Warsaw, Poland
| | - S Roth
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - A Rubbia
- Institute for Particle Physics, ETH Zurich, Zurich, Switzerland
| | - D Ruterbories
- Department of Physics and Astronomy, University of Rochester, Rochester, New York, USA
| | - R Sacco
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - K Sakashita
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - F Sánchez
- Institut de Fisica d'Altes Energies (IFAE), Bellaterra (Barcelona), Spain
| | - F Sato
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - E Scantamburlo
- Section de Physique, University of Geneva, DPNC, Geneva, Switzerland
| | - K Scholberg
- Department of Physics, Duke University, Durham, North Carolina, USA
| | - S Schoppmann
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - J Schwehr
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - M Scott
- TRIUMF, Vancouver, British Columbia, Canada
| | - Y Seiya
- Department of Physics, Osaka City University, Osaka, Japan
| | - T Sekiguchi
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - H Sekiya
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - D Sgalaberna
- Institute for Particle Physics, ETH Zurich, Zurich, Switzerland
| | - M Shiozawa
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), Todai Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan and Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - S Short
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - Y Shustrov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - P Sinclair
- Department of Physics, Imperial College London, London, United Kingdom
| | - B Smith
- Department of Physics, Imperial College London, London, United Kingdom
| | - M Smy
- Department of Physics and Astronomy, University of California, Irvine, Irvine, California, USA
| | - J T Sobczyk
- Faculty of Physics and Astronomy, Wroclaw University, Wroclaw, Poland
| | - H Sobel
- Department of Physics and Astronomy, University of California, Irvine, Irvine, California, USA and Kavli Institute for the Physics and Mathematics of the Universe (WPI), Todai Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - M Sorel
- IFIC (CSIC & University of Valencia), Valencia, Spain
| | - L Southwell
- Physics Department, Lancaster University, Lancaster, United Kingdom
| | - P Stamoulis
- IFIC (CSIC & University of Valencia), Valencia, Spain
| | - J Steinmann
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - B Still
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - Y Suda
- Department of Physics, University of Tokyo, Tokyo, Japan
| | | | - K Suzuki
- Department of Physics, Kyoto University, Kyoto, Japan
| | - S Y Suzuki
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - Y Suzuki
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), Todai Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - R Tacik
- Department of Physics, University of Regina, Regina, Saskatchewan, Canada and TRIUMF, Vancouver, British Columbia, Canada
| | - M Tada
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - S Takahashi
- Department of Physics, Kyoto University, Kyoto, Japan
| | - A Takeda
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - Y Takeuchi
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), Todai Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan and Kobe University, Kobe, Japan
| | - H K Tanaka
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - H A Tanaka
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - M M Tanaka
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - D Terhorst
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - R Terri
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - L F Thompson
- Department of Physics and Astronomy, University of Sheffield, Sheffield, United Kingdom
| | - A Thorley
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - S Tobayama
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - W Toki
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - T Tomura
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - Y Totsuka
- Department of Physics, University of Alberta, Centre for Particle Physics, Edmonton, Alberta, Canada
| | - C Touramanis
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - T Tsukamoto
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - M Tzanov
- Department of Physics and Astronomy, Louisiana State University, Baton Rouge, Louisiana, USA
| | - Y Uchida
- Department of Physics, Imperial College London, London, United Kingdom
| | - A Vacheret
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - M Vagins
- Department of Physics and Astronomy, University of California, Irvine, Irvine, California, USA and Kavli Institute for the Physics and Mathematics of the Universe (WPI), Todai Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - G Vasseur
- IRFU, CEA Saclay, Gif-sur-Yvette, France
| | - T Wachala
- H. Niewodniczanski Institute of Nuclear Physics PAN, Cracow, Poland
| | - A V Waldron
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - C W Walter
- Department of Physics, Duke University, Durham, North Carolina, USA
| | - D Wark
- Department of Physics, Imperial College London, London, United Kingdom and STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - M O Wascko
- Department of Physics, Imperial College London, London, United Kingdom
| | - A Weber
- Department of Physics, Oxford University, Oxford, United Kingdom and STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - R Wendell
- Institute for Cosmic Ray Research, University of Tokyo, Kamioka Observatory, Kamioka, Japan
| | - R J Wilkes
- Department of Physics, University of Washington, Seattle, Washington, USA
| | | | - C Wilkinson
- Department of Physics and Astronomy, University of Sheffield, Sheffield, United Kingdom
| | - Z Williamson
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - J R Wilson
- School of Physics and Astronomy, Queen Mary University of London, London, United Kingdom
| | - R J Wilson
- Department of Physics, Colorado State University, Fort Collins, Colorado, USA
| | - T Wongjirad
- Department of Physics, Duke University, Durham, North Carolina, USA
| | - Y Yamada
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - K Yamamoto
- Department of Physics, Osaka City University, Osaka, Japan
| | - C Yanagisawa
- Department of Physics and Astronomy, State University of New York at Stony Brook, Stony Brook, New York, USA
| | - T Yano
- Kobe University, Kobe, Japan
| | - S Yen
- TRIUMF, Vancouver, British Columbia, Canada
| | - N Yershov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - M Yokoyama
- Department of Physics, University of Tokyo, Tokyo, Japan
| | - T Yuan
- Department of Physics, University of Colorado at Boulder, Boulder, Colorado, USA
| | - M Yu
- Department of Physics and Astronomy, York University, Toronto, Ontario, Canada
| | - A Zalewska
- H. Niewodniczanski Institute of Nuclear Physics PAN, Cracow, Poland
| | - J Zalipska
- National Centre for Nuclear Research, Warsaw, Poland
| | - L Zambelli
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - K Zaremba
- Institute of Radioelectronics, Warsaw University of Technology, Warsaw, Poland
| | - M Ziembicki
- Institute of Radioelectronics, Warsaw University of Technology, Warsaw, Poland
| | - E D Zimmerman
- Department of Physics, University of Colorado at Boulder, Boulder, Colorado, USA
| | - M Zito
- IRFU, CEA Saclay, Gif-sur-Yvette, France
| | - J Żmuda
- Faculty of Physics and Astronomy, Wroclaw University, Wroclaw, Poland
| |
Collapse
|